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Abstract

THE GENOME SCALE METABOLIC MODEL OF CRYPTOSPORIDIUM HOMINIS:
iNV209
By Niti Vanee, B.Tech.
A thesis submitted in partial fulfillment of the requirements for the degree of Master of
Science at Virginia Commonwealth University.
Virginia Commonwealth University, 2009
Major Director: Dr. Gregory A. Buck
Director, Center for the Study of Biological Complexity

The apicomplexan Cryptosporidium is a protozoan parasite of humans and other
mammals. Cryptosporidium species cause acute gastro-enteritis and diarrheal disease in
healthy humans and animals, and cause life-threatening infection in immuno-compromised
individuals such as people with AIDS. It has a one-host life cycle and invades intestinal
epithelial

cells

causing

diarrhea,

or

more

rarely

the

pulmonary

epithelium.

Cryptosporidium carries out all the asexual reproductive stages like several other
apicomplexans. Current annotation of this organism predicts it to contain 3884 genes of
which only 1581 genes have predicted functions. By using a combination of bioinformatics
ix

analysis, biochemical evidence, and high-throughput data, a genome-scale metabolic
model of Cryptosporidium hominis is being constructed. The current model is comprised
of approximately 213 gene-associated enzymes involved in major metabolic pathways
including carbohydrate, nucleotide, amino acid, and energy metabolism. The approach of
constructing a genome-scale model provides a link between the genotype and the
phenotypic behavior of the organism, making it possible to study and predict behavior
based upon genome content. This modeling approach provides an overview for evaluating
missing components in a metabolic network and provides an analytical framework for
interpreting data as more research becomes available. The goal of constructing this model
is to systematically study and analyze various functional behaviors of C. hominis with
respect to its stages in life cycle and pathogenicity.

x

CHAPTER 1 INTRODUCTION

1.1

Cryptosporidium
Cryptosporidium is a protozoan parasite that belongs to the apicomplexa phylum. It

causes acute gastroenteritis and diarrhea. Many outbreaks in United States occurred in
water parks, community swimming pools and day care centers. Interest in the study of this
parasite has increased in the last two decades especially after the outbreak of
cryptosporidiosis in Milwaukee, Wisconsin in 1993 where approximately 403,000 people
were affected. It was the largest waterborne disease outbreak documented in the history of
United States (Kenzie et al., 1994). Transmission of Cryptosporidium occurs mainly
through contact with the contaminated water (e.g., drinking and recreational water). It is
resistant to chemical treatment of water, like chlorination, as it exists in the form of oocysts
when outside the host cell and these oocysts pass through the filtration systems of the
water supplies as well.
The two most studied species, C. hominis and C. parvum, which differ in host
range, genotype, and pathogenicity, are more relevant to humans. C.hominis infects only
humans, whereas C. parvum also spreads in other mammals. (Xu et al., 2004).

1

Figure 1: Infection cycle and life cycle of Cryptosporidium (adapted from
Cryptosporidiosis figure from Department of Health and Human Services)
2

1.1.1

Infection cycle and life cycle
Cryptosporidium is transmitted be the fecal-oral route via the oocyst stage. These

infections increase with close human-to-human contact and by contact with infected
livestock, zoo animals, or companion animals (Fayer, 1997).
Transmission of Cryptosporidium parvum and C. hominis occurs mainly through
contact with contaminated water (e.g., drinking or recreational water) as shown in Figure
1. Sometimes it may also be transmitted by food sources, such as chicken salad. Many
outbreaks in the United States have occurred in water parks, community swimming pools,
and day care centers.

Zoonotic and anthroponotic transmission of C. parvum and

anthroponotic transmission of C. hominis occur through exposure to infected animals or
exposure to water contaminated by feces of infected animals.
The life cycle of Cryptosporidium, shown diagrammatically in Figure 1, is complex
as it involves both sexual and asexual developmental stages. It begins upon the inhalation
or the ingestion of sporulated oocysts, which is the only exogenous stage, containing 4
sporozoites within a tough layered wall. It is excreted from the body of an infected host in
the feces. Following ingestion (and possibly inhalation) by a suitable host, excystation
occurs. The sporozoites are released and infect the epithelial cells of the gastrointestinal
tract or other tissues such as the respiratory tract. Here the parasites undergo asexual
multiplication (schizogony or merogony stages) and then sexual multiplication
(gametogony) producing microgamonts (male) and macrogamonts (female).

Upon

fertilization of the macrogamonts by the microgametes, oocysts are developed that
3

sporulate in the infected host. Two different types of oocysts are produced –
! The thick-walled, which is commonly excreted from the host, and
! The thin-walled oocyst, which is primarily involved in autoinfection.
Oocysts are infective upon excretion, thus permitting direct and immediate fecaloral transmission. (Department of Health and Human Services; Thompson et al., 2005)

Oocysts – Thick- as well as thin-walled oocysts are usually recovered from culture after
5 days of inoculation. Approximately 80% of the oocysts formed after the completion of
the life cycle are thick- walled oocysts, which are released from the host in the faeces if
present in the gastrointestinal tract, or via aerosols or nasal secretions if present in the
respiratory tract. However, about 20% of oocysts fails to form a thick oocyst wall and are
thus known as thin-walled oocysts. Thin-walled oocysts are important in autoinfection
through continuous recycling of sporozoites excysting from ruptures thin-walled oocysts.
(Thompson et al., 2005)

Sporozoites – are 5.2 X 1.2 !m in size and are characterized by having a comma shape
with a rounded posterior end and a pointed tapered anterior end. They actively move
inside the oocysts, excysting and exhibits gliding movement. (Thompson et al., 2005)

1.1.2 Maintenance and amplification of Cryptosporidium
Cryptosporidium species are not very well studied because culturing and
amplification of the organism of a big challenge. One of the major objectives of many
4

laboratories is to amplify the parasite and develop reproducible models of infection to
facilitate biological, pathological, immunological and molecular and drug evaluation
studies. There are two ways by which Cryptosporidium can be amplified: in vivo, in animal
models and in vitro using different cell lines.

1.1.2.1 Challenges faced in vivo.
The majority of in vivo infections have been carried out using the C. parvum cattle
genotype. Experimental infections with C. parvum have been successfully established in a
variety of domestic and laboratory animals, especially neonates, immunosuppressed or
immunodeficient animals. But there is a high level of difference in infectivity for
laboratory animals even between two closely related species of Cryptosporidium - C.
parvum and C. hominis. C. parvum cattle genotype can readily infect mice and cattle
whereas C.hominis does not infect them. (Peng et al., 1997)
In summary, Cryptosporidium does not support the infection with multiple
genotypes. Apart from this, the amplification of Cryptosporidium in animal models is
labor-intensive, expensive beyond the budget of most of the laboratories, and will not
support the growth of the parasite for long period of time. (Thompson et al., 2005)

1.1.2.2 Challenges faced in vitro
There are many factors that affect the development and proliferation of
Cryptosporidium in culture. These include the excystation protocol, age and strain of
parasite, stage and size of the inoculum, host cell types and maturity, and culture
5

conditions such as pH, medium supplements and atmosphere. (Thompson et al., 2005)
Although, major improvements in culturing Cryptosporidium in vitro have
occurred since 1984, infections could not be maintained for more than a few days and only
asexual phases of the parasite life cycle could be consistently maintained for short periods.
Efforts are going on in the direction to optimize the conditions for growth in order to
increase the number of parasite stages produced and days to maintain the culture for longer
period of time. (Thompson et al., 2005)

1.1.3 Host-pathogen interaction - disease caused
Cryptosporidium lives in the intestine of the infected humans and animals, is
transmitted by ingestion of oocycsts, and completes its life cycle in a single host (Figure
1). In healthy humans, the parasite is responsible for symptoms such as watery diarrhea,
abdominal cramps or pain, dehydration, nausea, vomiting, fever, and weight loss. Its major
impact has been among those with weakened immune systems, including, people with HIV
or AIDS or Transplant recipients. They may develop serious, chronic, and sometimes fatal
version of the illness (P. Xu et al., 2004). There is no therapy available so far to treat
patients suffering from cryptosporidiosis.
The time from ingestion of oocysts to the appearance of clinical signs is between 2
and 14 days. The first clinical signs associated with infection is, diarrhea, which may or
may not be associated with abdominal cramping. Severity varies from continuous
voluminous watery diarrhea to scant or intermittent diarrhea. Blood is infrequently
observed in the stool. Other clinical signs include general malaise, fever, and fatigue, loss
6

of appetite, nausea and vomiting. Dehydration and weight loss are also direct result from
the symptoms (Ramirez, et al., 2004).
In immunocompetent host, clinical signs last for 10-14 days, but in the
immunocompromised individuals they can persist for months to years. (Thompson et al.,
2005)

It is of particular concern for four reasons:
1. The oocyst is extremely resistant to disinfection and cannot be killed with routine
water-disinfection procedures;
2. The disease is not treatable with antibiotics;
3. The mortality from infection in severely immunocompromised patients can be as
high as 50-60%; and
4. Animal and human fecal wastes are associated with transmission of the disease to
humans. (Bates, 2007)

1.1.4 Genome of Cryptosporidium hominis
The parasite genome was sequenced in 2004 by Xu et al. describes that it has eightchromosome, approximately 9.2 mb genome size and contains an estimated 3994 genes. In
silico reconstitution of C.hominis biochemical properties reveal that basic metabolic
pathways are extremely streamlined. The parasite depends mainly on glycolysis for energy
production. It supports both aerobic and anaerobic metabolism. However, it shows limited

7

biosynthetic pathways and mainly relies on transporters. Following figure from Xu et al.
explains the major metabolic pathways inside the C.hominis. (Xu et al., 2004)

Figure 2: Predicted metabolic network inside C.hominis on the basis of genome annotation
(Xu et al., 2004)
1.2

Systems Biology
Genome Sequencing has enabled us to determine the biological components that

make up a cell or an organism. The new discipline of systems biology examines how these
components interact and form networks and how the networks generate the whole cell
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functions corresponding to observable phenotypes. The study of whole systems, with the
inclusion of genomic, proteomic, metabolomic, and fluxomic data together, is termed
Systems Biology (Figure 3).

Figure 3: Several elements that describe an organism (Fong, 2008)
This approach focuses on finding the relation between the genotype and phenotype
of an organism by using a network model, permitting a better understanding of the cellular
processes. Recently, many network models of various organisms have been constructed
and validated for use in biological prediction including Bacillus subtilis, Escherichia coli,
Saccharomyces cerevisiae, Human cardiac mitochondria and Human RBCs. (Joyce &
9

Palsson, 2007)

1.2.1 Modeling approach - Constraint Based Modeling
Bringing together all the potential biochemical reactions of an organism, builds up
a network chart of metabolic pathways however, in the biological world, cells are
subjected to various constraints from environmental, physiochemical, evolutionary, and
regulatory sources. By incorporating metabolic reactions as well as other above-mentioned
properties into the systemic network reconstruction, these models account for the
constraints that restrict an organism’s phenotypic behavior. Apart from constraints that
arise from network topology and stoichiometry, other constraints can be incorporated into
these models, e.g. experimentally determined maximum enzyme fluxes, thermodynamic
limitation, internal metabolic flux determinations, transcriptional regulation, etc. The
constraint-based modeling approach helps distinguish the networks states that a system can
achieve from those it cannot achieve rather than exactly predicting the network behavior.
(Joyce & Palsson, 2007; Raghunathan et al., 2009)

1.2.2 Mathematical algorithms used for optimization
Once the model is ready in the mathematical form we use mathematical
optimization algorithm to investigate the production capabilities and systemic properties of
the metabolic network (Joyce & Palsson, 2007; Shlomi et al., 2008).

10

1.2.2.1 Linear programming algorithm - Flux Balance Analysis
Flux Balance Analysis (FBA) is a type of analysis that imposes mass balance and
flux capacity constraints on the network and uses an optimization procedure to find a
steady-state flux distribution that maximizes the biomass yield of the cell without the need
for measurement of kinetic parameters. FBA relies on Linear programming based
optimization. We define an objective function of our network such as biomass production,
byproduct secretion, ATP production, etc. and try to optimize that objective. Linear
programming works on optimizing the flux distribution for the network model that
maximizes the stated objective. (Raman & Chandra, 2009; Roberts et al., 2009)

1.2.2.2 Mixed integer linear programming algorithm – MILP
Another type of optimization algorithm that is used in model analysis is MILP. It is
called so because it unlike FBA when we use this algorithm we get the results in terms of
integer (-1, 0, 1) that denoting if the reaction is in active state or inactive state and also
gives us the flux value of the reaction which may be any decimal value between -1000 to
1000. The flux values are calculated from by linear programming as in FBA.
MILP used in the current work is from Shlomi et al. and the basis for MILP is to
optimize the agreement between the two sets of information used (the metabolic model and
the proteomic or expression data). (Shlomi et al., 2008)
In the ideal situation, the reactions that are expressed implies that the proteins
coding for that specific reaction are active and the reactions that are inactive should mean
that the proteins are inactive. In the biological world its not an ideal situation i.e. there is a
11

possibility that a specific protein is found in the system but reaction is still in affective
because of other factors affecting it such as presence of substrate.
To better understand the functioning of MILP consider the following figure where
the region of interested is either the active state of reaction and protein or the inactive state
of reaction and protein and the aim is to maximize the information related to these 2
regions and minimize the false positive and negative region.

Figure 4: Optimization through MILP algorithm aims at maximizing the information
related to the shaded region where reactions and proteins are both found either active or
inactive and reducing the other regions. Note: false negative is the region where the protein
is found in the systems but the reaction is not present or active where as false positive
denotes the case where protein is absent in the system but the reaction is still expressed.
The region of false positive exists with the gene expression data where genes are highly
expressed or lowly expressed and not with the proteomic data.
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1.3

Metabolic modeling

1.3.1 Introduction
Detailed, comprehensive-modeling efforts led to the development of three types of
networks: metabolic networks, transcriptional regulatory networks and signaling networks
(Palsson, 2007). The most commonly reconstructed and used networks are the metabolic
networks that integrate the biochemical interactions present in the organism. Genome
annotation provides the basis for the initial prediction of metabolic enzymes and the
preliminary genome-scale model. Figure 4 shows the major steps involved construction
genome scale metabolic models.
Metabolic network interacts with essentially all other cellular processes. The
reconstruction of these processes and the integration of multiple networks will lead to the
description of a comprehensive range of cellular functions.
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Figure 5: Overall process of genome scale metabolic reconstruction (adapted from
Palsson, 2007)

The metabolic reconstruction requires mainly 4 steps:
Step 1: Network reconstruction, i.e. obtaining the genome annotation of
the target organism. Genome annotations are available at several only databases
such as, IMG (Integrated Microbial Genome), EntrezGene, CMR (Comprehensive
Microbial Resource), Genome Reviews (through EBI, European Bioinformatics
Institute), etc. Also there are several organism specific sources of genome like
EcoCyc for E.coli, SGD (Saccharomyces Genome Database), etc.
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Other databases such as KEGG, MetaCyc, Transport DB can be used to
provide metabolic and transport reaction that’s have been shown to occur in a range
of organisms. (Feist, et al., 2009)

Step 2: Refining the draft reconstruction. The draft reconstruction
created in previous step needs to manually curated, ideally with the inputs from
organism specific experts. This step of manual curation is labor intensive and
sometimes tedious. Organism- specific databases, textbooks, primary publication,
review articles, and experts familiar with the legacy data for an organism are the
main sources of information for the manual curation step. These sources of
information provide direct or indirect evidence for the inclusion of specific
reactions in the metabolic reconstruction. (Feist et al., 2009)

Step 3: Mathematical modeling and analysis of the network. Applying
mathematical algorithm to the curated biochemical to perform simulations and
analysis. Once the network was reconstructed, the list of metabolic reactions was
transformed into a stoichiometric matrix (S), i.e., the mathematical representation
of the reconstructed network. The S matrix dimensions are m x n, where m is the
number of metabolites and n is the number of reactions. Each element Sij represents
the stoichiometric coefficient of metabolite i in reaction j. If the metabolite in a
particular reaction is a reactant, the coefficient is negative (the metabolite is
consumed by the reaction); if it is a product, the coefficient is positive (the
15

metabolite is produced by the reaction). The S matrix was then used as the basis of
further analysis, i.e., Flux Balance Analysis. FBA uses linear programming based
optimization to identify a particular flux distribution distribution (a single point in
the multidimensional space of possible metabolic behaviors) that optimizes a given
metabolic objective (see Biomass Equation, below). The LP optimization problem
is formulated as:

Maximize Z,
Subject to S " v = 0,
ai < vi < bi for all reactions i.
Z is the objective function; for this study, Z was defined as the biomass
equation. The second two statements are the flux constraints. S is the stoichiometric
matrix defined above. Each reaction flux is subject to lower and upper bounds, as
indicated (in cases where these are not known, ai and bi are set to some arbitrary
numbers that exceed any feasible internal flux). The solution to this problem is an
optimal flux distribution, v, a vector that contains flux values for each reaction in
the network. The solution is optimal in the sense that it maximizes the flux through
the objective Z.
Mathematically, S is a transformation of the reaction flux vector, v, to a
vector of time derivatives for each metabolite concentration:

S " v = dx/dt.
16

Since the time constants for metabolic transients are fast (< tens of
seconds), but the time constants for cell growth are long (hours to days), the
metabolites can be considered as existing in a quasi-steady state (Joyce & Palsson,
2007). This leads to the second equation of the LP optimization problem above.
Because of the emphasis on steady states, assumptions regarding reaction kinetics
are not needed.

Biomass Equation: In FBA, optimization is used to find a particular flux
distribution that maximizes a given metabolic objective. Typical metabolic
objectives chosen for optimization include maximization of ATP production,
byproduct secretion, or biomass production. In our work, we chose to optimize
for biomass production (Roberts et al., 2009). Biomass production is
represented in our model by an additional metabolic reaction. Its reactants
include such critical metabolites as ATP, acetyl-CoA, and NADPH; its products
include ADP, inorganic phosphate, and other metabolites that represent
byproducts of anabolic metabolism.

Step 4: Integration of the high-throughput data. Further, the specific
experimental or stage specific or tissue specific expression data or proteomic data
is integrated with the existing comprehensive reconstructed metabolic network to
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study the organisms’ performance with respect to the data and thus make further
predictions.

1.3.2 Application
Such model once completed can be applied to study the specific growth condition
from which the training data were based and can be used to explore additional
environmental condition. Network reconstructions help us to build mechanistic genotypephenotype relationships and thus obtain quantitative (such as, what is the cellular growth
rate) and qualitative (such as, will the organism grow in a particular condition) predictions
about the organism. (Feist et al., 2009)
In recent year with the growing popularity of the systems biology approach of
solving biological problem, researchers from various fields have tried the metabolic
reconstructs to analyze the target organism and explain the basis behind some of the
previously discovered facts (de Figueiredo et al., 2008). Some of the important
applications of metabolic model reconstruction include, optimization of production of
certain metabolites (Hjersted & Henson, 2009), study host pathogen interaction
(Raghunathan et al., 2009), studying single gene deletions (Xu, Sun, & Yu, 2009) or gene
knock out screening (Plaimas et al., 2008) or identifying novel antimicrobial drugs targets
(Lee et al., 2009).

1.4

Parasite study and metabolic modeling
In context of pathogenic organisms, a metabolic reconstruction has a potential to
18

plays important role in drug discovery. With the completion of genome projects of several
parasites, there are efforts going on to make sense of that information in terms of genes,
their products, interactions in growth and development and survival of parasite. (Wambua,
Mcconkey, & Westhead, 2009)

1.4.1 Predicting new drug targets
Genomic information provides an accurate picture of the metabolic reactions that
are present in the organism. With the analysis of essential reactions from the whole
network we can predict the enzymes or transporters that might be viable targets for few
new drug target.

1.4.2 Comparative genomics of host and pathogen metabolism
In the study for potential drug targets against the pathogens, one of the most area of
study is the interaction between the host and pathogen. Many parasites are found to have
lost pathways that are essential for free-living species. For example, Mycoplasm genitalium
contains 580 genes (Suthers et al., 2009), C. parvum lacks Kreb’s cycle enzymes (Fayer,
1997). Often, they depend on the host cell for these incomplete but required missing links.
These kinds of interactions between host and pathogen can be compared and studied as
potential targets to fight against parasitic disease.
In the current project a metabolic model of parasite Cryptosporidium hominis is
constructed and integrated with proteomic data, and analyzed to make further predictions.

19

CHAPTER 2 METHODS

2.1

Reconstruction process – genome to metabolic network
The process of reconstructing the metabolic network of C.hominis is shown in Figure

5. The overall process is divided into 4 major steps:
Step 1. Network reconstruction
Step 2. Network refinement
Step 3. Network analysis and simulation
Step 4. Proteomic data integration
In brief, the reconstruction process starts with genome annotation that defines the list
of functionally identifiable genes present in C.hominis (P. Xu et al., 2004). This serves as
the basis for a set of possible reactions that are catalyzed by these annotated gene products
(enzymes coded by genes). Tables 1 and 2 contain information on the online genome and
pathway databases and key references used for the reconstruction process.

20

Figure 6: Summary for the C.hominis metabolic network reconstruction
Database
Genome Database:
CSBC Cryptosporidium hominis research
Integrated Microbial Genomes (IMG)
Pathways and other databases
KEGG
Transport Classification database (TCDB)
Gene Protein Reaction (GPR)
Uniprot

Link
http://www.hominis.mic.vcu.edu
http://img.jgi.doe.gov
http://www.genome.jp/kegg/pathway.html
http://www.tcdb.org/
ftp://ftp.genome.jp/pub/kegg/genes/organis
ms/cho/cho_xrefall.list

Table 1. Online resources for the reconstruction of metabolic network of C. hominis

21

Metabolism
Complete metabolism overview
Carbohydrates
Energy
Nucleic acid
Amino acid
Fatty acids

References
Thompson et al. 2005
Thompson et al. 2005
Thompson et al. 2005
Thompson et al. 2005
Fritzler et al. 2007
Mazumdar et al. 2007
Thompson et al. 2005

Table 2. Key references consulted additional to the online resources for the reconstruction
of metabolic network of C. hominis
2.2 Refining the model
EC numbers from the genome annotation were used to look for all possible
reactions catalyzed by each enzyme. This created the list of possible reactions in the
model. Also the gene IDs were added to the model for each reaction to create Gene
Protein Relation (GPR) files file for further usage.
A list of metabolites required by the set of reactions was compiled within a Source
file and also there was a compiled list of byproducts, as Escapes file were created with
literature reviews of closely related species model available. These files were revised with
data available for C.hominis experimental information and with simulation runs. Also,
draft biomass equation was derived based on the existing equation for B. subtilis (Oh et al.,
2007), as qualitative results of FBA are relatively insensitive to minor mis-specification of
the coefficient values. The goal is to eventually have experimental values for C.hominis.
All these files contain necessary inputs for steady state operation and simulate the
availability of certain metabolites in culture medium.
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2.3 Analysis of network using Metmodel and FBA
2.3.1 Gap analysis
The Python-based framework, Metmodel (Roberts & Buck, 2007) was used to build
and analyze an initial genome scale model of metabolism of C.hominis. The model is
stored in a series of text file. Metmodel uses these files as input, performs FBA and outputs
the predicted fluxes for each reaction in the model, given a set of objective (biomass
production). Some of the reactions were added after the first simulation run as the original
network/annotation was found to have gaps.

Gap filling, also known as filling pathway holes, is a procedure for including
the reactions that might be important and necessary to complete certain
pathway for which only one or two reactions are missing. Most of the time it is
possible that these reaction are present in the organism but the enzymes
responsible for these reactions are not annotated in the genome, as there are
several hypothetical proteins that are yet to be studied for their function. There
is a possibility that these hypothetical proteins might code for some of these
missing reaction.

2.3.2 Essential reaction
Metmodel also helped in finding the essential reaction, i.e. the subset of lethal
reactions in the model. The steps of determining them were as follows:
For each reaction, X:
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1.

Set the upper and lower bounds of reaction X to zero by setting up constrain on
the reaction to have zero flux. This simulates the loss of reaction.

2.

Run FBA,
! If objective value from FBA run comes out to be 0 (or ~ 0), the reaction is
predicted to be lethal which means that there is no growth when the reaction
is inactivated.
! If not, then the reaction is predicted to be non-lethal, i.e. the parasite can
still grow, even though reaction is inactivated.

2.4

3.

Reset the upper and lower bounds of reaction X to their original values.

4.

Continue to next reaction.

Integrating the proteomic data with the model
As mentioned in the figure 1, parasite has a life cycle and the first two stages –

oocysts and sporozoite were analyzed in terms of proteomic composition. Unpublished inhouse proteomic data that’s was used in this project describes the list of active proteins in a
specific stage. This information was used to active or inactive the reactions in the model
and see how the model will perform. This stage specific proteomic data was integrated
with an optimization algorithm from Shlomi et. al (Shlomi et al., 2008).
The graphical representation of the performance of metabolites in the 2 stages was
shown using python based program designed in the laboratory. Figure 7 shows the
graphical representation of the difference between the 2 stages. The following graph
includes the metabolites that are used in highly different way in two stages. To draw this
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chart, the difference in the conditions of both the stages was determined; all the
metabolites involved in these conditions were listed. A score was assigned to these
metabolites depending on the level of difference of usage of these metabolites in both the
stages (i.e. highly different manner ~ highest score). Then the score was ranked and a
threshold was set. To draw the final chart, the top list of metabolites was used.

25

Figure 7: Graphical representation of comparative analysis of 2 stages oocyst and
sporozoite in Cryptosporidium hominis depending upon the unpublished in-house proteomic
data. Blue arrows shows oocyst stage activity and red arrows denote the sporozoite stage
activity. This graphical representation only includes the reactions that show maximum level
of difference only
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CHAPTER 3 RESULTS

3.1

Metabolic Reconstruction
The iNV213 network reconstruction accounts for the function of 213 genes and

includes 540 reactions with 514 metabolic reaction (including inter-conversion reactions of
some metabolites) and 26 are extra-cellular transport reaction. Due to lack of direct
biochemical evidences for many reactions, information from genomic data, literature
derived conclusions and information from the related organism is used to evidences used to
include these reaction in the model. Despite the fact that C. hominis is a Eukaryote, the
current model contains only one intracellular compartment – the cytosol - as there is not
much of information available in terms of compartments and specific pathways that take
place inside of the organism.
Figure 8 provides an overview of reactions of iNV213. Among, the pathways
included in the model, carbohydrate metabolism seem the most functional metabolism
network with glycolysis as one of the complete metabolic pathway. However, other
metabolic network includes many reactions that are the inter-conversion reactions.
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Figure 8: Reactions distribution in the model under several metabolic pathways.
Miscellaneous reaction is the set of reactions that were required for the model but could
not be categorized under specific metabolism network. Nucleotide metabolism, which is
found to have maximum number of reaction in the network, actually comprises of multiple
reactions that are coded by single enzymes but exact evidence could not be found to filter
them and get the exact minimal set of reactions. Conclusively, carbohydrate metabolism
was found to be the most functional and complete network in the model. After completion
of reconstruction network a small set of reactions was added to the network to make it
functional and yellow bars in each of the metabolic pathways highlights these reaction.
Above figure shows the reaction distribution of each of the metabolic pathway.
Genomic evidences support the completeness of metabolic networks such as, Energy
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metabolism, glycan metabolism, metabolism of secondary products, and metabolism of
other amino acids but some minor additions were required in the amino acid metabolism (3
reactions), carbohydrate metabolism (3 reactions), and nucleotide metabolism (7
reactions). Lipid metabolism accounts for 117 reactions with genomic evidence for 87
reactions. Other 30 reactions were added through gap analysis to complete the metabolic
network to of the organism. These reactions are explained in next section of gap analysis.

Figure 9: Graphical representation of carbohydrate metabolism network that was found to
be the active
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3.2

Gap analysis – filling the missing links
The next important step in completion of the model was filling up the missing links

- the gaps. There were some of the reactions added to the original iNV213 after performing
the FBA simulation. This process is termed as gap analysis in network modeling. These
reactions are required in order to complete certain pathways e.g., lipid metabolism cannot
be functional if these 30 reactions (Supplementary file 2) are absent in the network.
Similarly, there is a small set of reaction added to many other pathways including fructose
mannose metabolism, glycolysis / gluconeogenesis, aminosugar metabolism, tyrosine
metabolism, extra-cellular transport reactions, valine, leucine and isoleucine biosynthesis,
pyrimidine metabolism and purine metabolism. There is a set of 29 reactions added to the
model through gap analysis but their exact sub systems were not studied. These reactions
are listed in the supplement data file 2 but are not included in the following figure of gap
analysis reactions chart.
For some of these reaction filled in lipid metabolism by gap analysis, the enzymes
responsible for them were further checked in genome of C. hominis. This was done by
isolating the hypothetical protein sequences from the whole genome of C.hominis and
performing the translated nucleotide BLAST against non-redundant protein sequences to
see if there genome annotation can be updated after the developments since 2004 when this
genome was last annotated. This might help us answer some of the questions about the
reactions added through the gap analysis. At the current stage of this procedure, no
significant matches were found but efforts are going on to optimize the search process.
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Figure 9: Distribution of reactions added to the known metabolic networks by gap analysis algorithm. Almost 50% of the
reactions are found to fill the gaps in lipid metabolism with most of the reaction in fatty acid biosynthesis, biosynthesis of
steroids, glycerophospholipid metabolism and sphingolipid metabolism
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3.3

Essential reaction
Simulation runs using Metmodel also helped in predicting the lethal reactions from

the model. 52 reactions were found to be essential using the deletion prediction algorithm
(described above). Summary of those lethal/essential reactions is shown in figure 10.
When performing the iterative flux balance analysis to study for reaction deletions it was
observed that eliminating reaction either reduces the optimal flux value or does not affects
it at all. However, when any of these 52 reaction were removed or masked in the model the
optimal flux value became negative which denotes there is no growth seen in the model if
these reactions are absent from the pathway network.
Figure 10 shows the lethal reaction distribution among the respective pathways.
Individual analysis of each of these reactions and comparing them with the ones added
through gap analysis showed that some of these reactions that were found lethal were
added in the process of gap analysis eg. in the fatty acid metabolism, 16 reaction were
found lethal out of which 9 reactions were added to the model by gap analysis algorithm.
Also, among the 3 important reactions of the glycerophospholipid metabolism all of them
were added in the above step to complete the metabolic network chart. Other predicted
lethal reaction include 5 reactions (out of 10) were found to be lethal. This prediction is
well supported by all the previous literature about importance of glycolysis in
Cryptosporidium. Glycolysis is the fully functional and active pathway in the organism and
the major source of energy production as well (Thompson et al., 2005). The lethal
reactions found in glycolysis are listed in table 3.
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Figure 10: Predicted number of essential reaction in the respective pathway. Green bars
denote the lethal reactions found in each of the metabolic pathway where as the yellow bar
shows the subset of those lethal reactions, which were included in the model by gap
analysis algorithm
Apart from these, other lethal reactions were from some of the amino acid
metabolism (arginine and proline metabolism, glutamate metabolism), lipid metabolism
(glycerolipid, and glycerophospholipid metabolism), NAD metabolism, and nucleotide
metabolism.
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Reaction
number in
Glycolysis
Reaction #
4

Enzyme

Reaction

Function

Fructose
bisphosphate

Split Molecule in half:
fdp <==> dhap + g3p

Reaction #
5

Glyceraldehyde3-phosphate
dehydrogenase

Oxidation/Phosphate Ester
Synthesis:
g3p + nad + pi <==> 13dpg + h +
nadh

Reaction #
7

Phosphoglycero
mutase

Isomerization:
2pg <==> 3pg

Reaction #
8

Enolase

Alcohol Dehydration:
2pg <==> h2o + pep

Reaction #
9

Pyruvate kinase

Phosphate Ester Hydrolysis;
Synthesis of ATP:
adp + h + pep --> atp + pyr

The six-carbon fructose diphophate is split into two
three-carbon compounds, an aldehyde and a
ketone.
This reaction is first an oxidation involving the
coenzyme NAD+. The aldehyde is oxidized to an
acid as an intermediate through the conversion of
NAD+ to NADH + H+. Then an inorganic
phosphate is added in a phosphate esteer synthesis.
In this reaction the phosphate group moves from
the 3rd position to the 2nd position in an
isomerization reaction.
In this reaction, which is the dehydration of an
alcohol, the -OH on C-3 and the -H on C-2 are
removed to make a water molecule. At the same
time a double bond forms between C-2 and C-3.
This change makes the compound somewhat
unstable, but energy for the final step of glycolysis.
This is the final reaction in glycolysis. Again one
of the phosphate groups undergoes hydrolysis to
form the acid and a phosphate ion, giving off
energy. This first energy producing reaction is
coupled with the next endothermic reaction making
ATP. The phosphate is transferred directly to an
ADP to make ATP.

Table 3: Lethal reactions predicted in glycolysis and their function in the pathway (Ophardt, 2003)
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3.4

Integrating the proteomic data
Summary of integration of proteomic data with metabolic network can be found in

the attached supplementary data file (Appendix D). Out of all the predicted reactions, it
was found that 48 reactions were common between both the stages oocyst and sporozoite
but 12 reactions were found to be present only in oocyst stage and 14 reactions were listed
under sporozoite stage only. An important point to be noticed in the result was that
glucokinase is active in sporozoite stage but not in oocyst stage on the other hand
hexokinase is active in oocyst stage. Hexokinase in known to have more affinity for
glucose where as glucokinase shows less affinity for glucose. This is justified observation
as during the sporozoite stage when parasite if inside host cell it has sufficient supply of
glucose and thus can afford to have active glucokinase activity where as when in oocyst
stage the supply of glucose is not sufficient and thus hexokinase is active instead to make
the carbohydrate metabolism work during minimal glucose concentration. Glucokinase
activity can be rapidly amplified or damped in response to changes in the glucose supply.
Graphical representation of difference in metabolite performance in 2 stages is shown in
figure 7.
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CHAPTER 4 DISCUSSION

4.1

Model
Previous research has shown that C. hominis relies mainly on glycolysis for its

energy metabolism (Thompson et al., 2005; Zhu & Rider Jr, 2009). The current annotation
of its genome, (P. Xu et al., 2004; Integrated microbial genome.) suggests the absence of
several biosynthetic capabilities such as synthesis of major amino acids and nucleotides
and appears to rely mainly on the extra cellular transport reactions (approximately 69
proteins are annotated as transporters (P. Xu et al., 2004)). Nucleotide and amino acid
includes salvage and inter-conversion pathways, but not the reactions for de novo synthesis
since the parasite lacks that capability. Also, uptake of sugar, and amino acids in the model
are facilitated by set transport reactions but the nucleotide and fatty acid uptake mechanism
is not well understood and is therefore not completely discussed in the model. Fully
functional glycolysis pathway as seen in iNV213 is supported by previous biochemical
evidence (Fayer, 1997; Thompson et al., 2005; Zhu & Rider Jr, 2009), however some
aspects of lipid in C. hominis are still not well understood. There is an ongoing analysis of
the model to predict more such biochemical facts about the parasite to understand the
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systems better and develop new, testable hypotheses.

4.2

Filling the gaps
Cryptosporidium lacks many important links in the minimal set of metabolic

pathway that is required for its successful replication and thus, the first simulation runs
showed that the reconstructed model is incomplete and lacks some metabolic reactions.
Resolving these metabolic gaps entails expanding the model by identifying and including
missing biochemical activities. This process basically consists of two steps: (1) identifying
plausible candidate reactions that could complete the model and (2) finding genes that
could catalyze the hypothesized activities. The current work completes the filling of gaps
however, finding gene for the hypothesized activity is one of the future directions for the
project.
Lipid metabolism was the metabolic network where most of the reactions were
inserted to complete the reaction flow and get the optimal flux. These 30 reactions were in
several categories respectively fatty acid metabolism, biosynthesis of steroids,
glycerophospholipids, and shingolipids. Many previous and ongoing research suggest that
these reactions, especially the glycerophosphlipids metabolism and biosynthesis of steroids
are putative drug targets sites for apicomplexans. (Clastre et al., 2007; Ralph, D'Ombrain,
& McFadden, 2001; Wambua et al., 2009) It is predicted that the reactions that are added
through gap analysis in lipid metabolism might be the required reaction for completion of
lipid metabolism but literature suggests that Cryptosporidium lacks the MEP pathway
(Clastre et al., 2007) and therefore it can be predicted that they depend on the host cell for
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these set of reaction. This opens up a prospect to individually analyze the subset of
reaction added to the lipid metabolism to study the host – parasite interaction. As these
reactions specially the ones added in glycerophospholipid mechanism are well-studied
putative drug targets is other apicomplexans. Also, this information may be useful in
determining minimal culture media requirement for the in vitro culturing of organism.
A noticeable addition to the glycerolipid pathways in this step was a phospholipase
A2 catalyzed hydrolysis of phosphatidyl choline. However, there is a patent pending
regarding use of phosphlipase A2 as biocides that neutralizes C. parvum sporozoite.
(Homan, Imboden, Riggs, Carryn, & Schaefer, 2006) Thus, accuracy and eligibility of this
addition of this reaction could not be established.
In a recent review, Zhu et al. (2009) explain the lipid metabolism to a great extent
but still there is no evidence for the biosynthetic capabilities of fatty acids in the C.
hominis. But since these reactions are predicted to be required for the metabolic network to
complete it might be possible that the parasite depends on host cell for some of these
reactions. This finding again leads to these questions: If the parasite needs these reactions
for the metabolic network to complete can any of its hypothetical proteins code for any of
these reactions? If not, then is it possible to answer question related to the transport
mechanism to support the entry of these lipids into the pathogen?
To answer the first question, some of these functional proteins that coded for the
newly added reaction were searched in the C. hominis genome. So far, no significant
matches were found hence with the current understanding of model, no information could
be added to the current genome annotation. This however opens up a prospect to perform
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homology search for the specific proteins to reanalyze the subset of hypothetical proteins
and also to study the transport mechanism of these lipids to update the list of transporter
proteins in the parasite.
Another interesting link added to the model was in amino sugar metabolism
pathway. UDP acetylglucosamine epimerase catalyzes the reaction involving UDP-Nacetyl-D-glucosamine. This reaction and enzyme is important in cyst-wall formation and
Jarroll et al. suggest that this can be a putative drug target for cyst-walled protozoan.
(Jarroll & Sener, 2003)

4.3

Essential reactions
The analysis of the essential reactions in the model is the most important outcome

as this expected to determine the major potential drug target sites specific to C.hominis.
From the subset of 52 reactions, Table 3 lists the 5 essential reactions of the glycolysis
pathway, which accounts for almost 50% of the glycolysis reaction. But since glycolysis is
an active pathway for all the host cells also, it does not prove to be a right direction to look
for drug targets. An important extension of the work is to determine which of these lethal
reactions are not affecting the human metabolic network. Attacking those sites might be
useful in determining the weak link for the parasite.
This reaction deletion approach can be used to find the performance of the cell in
presence of enzyme inhibitors. Thus, if reaction X is predicted to be lethal, and an inhibitor
of that enzyme is available, then the model can predict what will be the probability of
growth of parasite in the presence of inhibitor. And this can be useful find the infection
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neutralization chemicals (the enzyme inhibitors).

4.4

From reaction deletion to gene knock out
The ultimate aim of such model reconstruction is to extend the analysis to study

gene knockout experiments in silico. The reaction deletion approach is useful to find out
important reactions in the metabolic network. The GPR (Gene Protein Relation) file was
used to study the relation of genes and proteins (enzymes) to determine which gene were
important in the metabolism network of parasite.
The supplement data file 3 provides the list of important genes that code for the
lethal reactions in the metabolic network. These genes can be computationally switched on
and off to study how the flux distribution would change in the presence or absence of a
particular gene. Gene knockout experiments may again be useful to find putative drug
targets for Cyrptosporidium. Some previous studies have shown how this approach can be
made useful in predicting essential genes (Lee et al., 2009; Oh et al., 2007; Pinney et al.,
Nov 2007; Plaimas et al., 2008; Wambua et al., 2009). These genes will then be studied as
potential drug targets that could be used to develop novel antibodies.

4.5

Conclusion
Genome-scale models integrate various types of data (genomic, expression and

proteomic) and allow modeling of the integrated functions of an organism. It is a powerful
tool that facilitates understanding of the whole system of an organism rather than focusing
on a particular component or segment. This model-based study can be used to help
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researchers prioritize experimental projects and save considerable time at the bench.
Beyond serving as a tool for basic biological research, this computational approach also
has potential medical and drug development relevance, e.g.: in pathogenic microbial
models, each gene that is predicted to be essential by constraint based modeling and
analysis, represents a potential drug target that could be used to develop novel antibiotics
in future. Also, the network analysis of human biology may help us in detecting several
therapeutic targets and thus provide a platform for assessing potentially adverse effects of
novel treatments (Mo & Palsson, 2009). The flexibility of constraint-based models will
lead to exploration of countless exciting biological questions in the future.
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CHAPTER 5 FUTURE DIRECTIONS

5.1

Refining model
There are lot of questions unanswered in terms of nucleotide metabolism, and lipid

metabolism. The metabolic networks needs to be more refined with some more literature,
biochemical or experimental evidences that individually focus on each of these reactions.
For example, in nucleotide metabolism there are many enzymes that work in multiple ways
and catalyze more than one reaction (in some cases around 20 reaction) but there were no
evidences how so ever to include or exclude any of those multiple reaction. Similar cases
were found in lipid metabolism as well. These reactions can be selected by studying the
parasite specifically in terms of nucleotide and lipid composition. This question can be
answered by some of the facts such as preference of substrate, behavior of organism under
specific condition or stages.

5.2

Finding the hypothesized function related gene
With the gap analysis there are several hypothetical functions added to the

metabolic network of the parasite. From the pool of hypothetical proteins these function
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related genes could be determined. A specific enzyme codes each of the reaction added by
gap analysis. If we can find out all the possible nucleotide sequence that may code for
these protein and compare it with the hypothetical proteins of C.hominis it is possible that
this may help to update the genome annotation for the organism

5.3

Host pathogen interaction
This pathogen depends on its host for various essential nutrients that support life,

and experimental determination of its growth requirements has proven difficult. As seen in
the gap analysis and essential reaction analysis there are several reactions related to lipid
metabolism which suggest the presence of fatty acid, steroid, glycerolipid biosynthetic
capabilities however, previous biochemical findings do not support this result. It might be
possible that the pathogen uses the host cell’s biosynthetic capabilities for its survival in
these cases. Analysis of this subset of reaction can be done in host cell to study how
parasite might get this support of lipid metabolism to complete its growth requirement.
This narrows down the list of reaction or pathways to focus on.

5.4

Culturing condition optimization
It is known that perfect culturing media composition could not be established for

C.hominis growth (explained in section 1). From the gap analysis we have found some of
the proteins that may be required by the organism but are not present in it. Experiments can
be performed to see if addition of these enzymes in the culture media affects the growth in
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some way. If the minimal media list can be derived by all these analysis it is possible to
optimize its growth initially in silico then in vitro.
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Appendix A: Metabolic Network Reactions included in the Model iNV213

REACTION IDs

R_BIOMASS
R_ALAR
R_ASPTRS
R_ASNTRS
R_ALATRS
R_PETHCT
R_CHLP
R_CYANST
R_GF6PTA
R_UDPACGLP
R_UAGDP
R_UAG4E
R_ACGAMPM
R_PROAKGOX1
R_NOS2
R_NOS1
R_3MOXTYROX
R_APRTO2
R_MHISOR
R_MAOLNOR
R_4HGLSD
R_HPROym
R_PHCD
R_4HGLSDm
R_PYR5CDm
R_PUTA3
R_P5CR
R_HPROb
R_HPROa
R_P5CRm
R_P5CRx
R_PRO1x
R_PROTRS
R_ARGTRS
R_DXPS
R_CDPMEK
R_MEPCT
R_BACCL
R_HACD1
R_HACD2
R_HACD3
R_HACD4
R_HACD5
R_HACD6
R_HACD7
R_PGK
R_RPI
R_OIVD1
R_MECDPS
R_CYSTRS
R_MCOATA
R_KAS2
R_KAS8
R_KAS13
R_KAS141
R_KAS7
R_KAS17
R_KAS100iso
R_KAS130iso
R_KAS1
R_KAS3
R_KAS6
R_KAS11
R_KAS180iso
R_KAS5
R_KAS9
R_KAS4
R_KAS12
R_KAS10
R_ALCD19
R_34DHOXPEGOX
R_LNS14DM
R_MELATNOX
R_FACOAL1813
R_FACOAL1812
R_FACOAL150
R_FACOAL2042
R_FACOAL1831
R_FACOAL1832
R_FACOAL241
R_FACOAL170
R_FACOAL244_1
R_FACOAL182
R_FACOAL181
R_FACOAL180
R_FACOAL184
R_FACOAL141
R_FACOAL140
R_FACOAL226i
R_FACOAL1822
R_FACOAL1821
R_FACOAL161
R_FACOAL160
R_FACOAL200
R_FACOAL203
R_FACOAL204
R_FACOAL205
R_FACOAL206
R_FACOAL226
R_FACOAL224
R_FACOAL240
R_FACOAL260
R_FACOAL245_2
R_FACOAL245_1
R_FACOAL191
R_FACOAL246_1
R_FACOAL2251
R_FACOAL2252
R_DHFR
R_FOLR2
R_AKP1
R_HEX7
R_HEX10
R_PFK26
R_MAN1PT
R_MAN1PT2r
R_FBA4
R_FBA5

GENE IDs

.
Chro.50329
Chro.80047
Chro.80047
Chro.60075
Chro.70332
Chro.80135
Chro.40314
Chro.10420
Chro.40100
Chro.40100
.
Chro.40374
Chro.30441
Chro.40304
Chro.40304
Chro.21000
Chro.21000
Chro.21000
Chro.21000
Chro.70551
Chro.70551
Chro.70551
Chro.70551
Chro.70551
Chro.70551
Chro.60426
Chro.60426
Chro.60426
Chro.60426
Chro.60426
Chro.60426
Chro.60505
Chro.50402
.
.
.
Chro.20303
Chro.30048
Chro.30048
Chro.30048
Chro.30048
Chro.30048
Chro.30048
Chro.30048
Chro.70113
Chro.10337
.
Chro.60125
Chro.40326
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Chro.80199
Chro.80199
Chro.21001
Chro.21001
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.40506
Chro.40506
Chro.70170
Chro.60435
Chro.60435
Chro.50115
Chro.20192
.
Chro.10335
Chro.10335

EC NUMBER

ENZYME NAME

PATHWAY

REACTION

.
biomass
Biomass Equation
[c] : 0.257980584 ala-L + 0.176597196 arg-L + 0.218152121 asn-L + 0.230278549 asp-L +
5.1.1.1
alanineracemase
Alanine and Aspartate Metabolism
[c] : ala-L <==> ala-D
or Chro.70182 or Chro.70181
6.1.1.12
or Chro.40267
Aspartyl-tRNAsynthetase
Alanine and Aspartate Metabolism
[c] : asp-L + atp + trnaasp --> amp + asptrna + ppi
6.1.1.22
Asparaginyl-tRNAsynthetase
Alanine and Aspartate Metabolism
[c] : asn-L + atp + trnaasn --> amp + asntrna + ppi
6.1.1.7
Alanyl-tRNAsynthetase
Alanine and Aspartate Metabolism
[c] : ala-L + atp + trnaala --> alatrna + amp + ppi
2.7.7.14
phosphoethanolaminecytidyltransferase
Aminophosphonate Metabolism
[c] : ctp + ethamp + h --> cdpea + ppi
2.7.7.15
cholinephosphatephosphatase
Aminophosphonate Metabolism
[c] : cholp + h2o --> chol + pi
2.8.1.1
Cyanidesulfurtransferase
Aminophosphonate Metabolism
[c] : cyan + tsul --> h + so3 + tcynt
2.6.1.16
glutamine-fructose-6-phosphatetransaminase
Aminosugar Metabolism
[c] : f6p + gln-L --> gam6p + glu-L
or Chro.70213
2.7.7.23
UDP-N-acetylglucosaminediphosphorylase
Aminosugar Metabolism
[c] : acgam1p + h + utp <==> ppi + udpacgal
or Chro.70213
2.7.7.23
UDP-N-acetylglucosaminediphosphorylase
Aminosugar Metabolism
[c] : acgam1p + h + utp --> ppi + uacgam
5.1.3.7
R_UDP_N_acetylglucosamine_4_epimerase
Aminosugar Metabolism
[c] : 1.0 uacgam --> 1.0 uacgala
5.4.2.3
phosphoacetylglucosaminemutase
Aminosugar Metabolism
[c] : acgam6p <==> acgam1p
1.14.11.2
L-Proline,2-oxoglutarate:oxygenoxidoreductase(4-hydroxylating)(ER)
Arginine and Proline Metabolism
[c] : akg + o2 + pro-L --> 4hpro-LT + co2 + succ
1.14.13.39
NitricOxideSynthase(NOforming)
Arginine and Proline Metabolism
[c] : nadph + 2 nwharg + 2 o2 --> 2 citr-L + h + 2 h2o + nadp + 2 no
1.14.13.39
NitricOxideSynthase(intermediateforming)
Arginine and Proline Metabolism
[c] : arg-L + h + nadph + o2 --> h2o + nadp + nwharg
1.4.3.4
_3-Methoxytyramine:oxygenoxidoreductase(deaminating)Arginine and Proline Metabolism
[c] : 3moxtyr + h2o + o2 --> 3mox4hpac + h2o2 + nh4
1.4.3.4
N-acetylputrescine:oxygenoxireductase(deaminating)
Arginine and Proline Metabolism
[c] : aprut + h2o + o2 --> h2o2 + n4abutn + nh4
1.4.3.4
N-Methylhistamine:oxygenoxidoreductase(deaminating) Arginine and Proline Metabolism
[c] : h2o + mhista + o2 --> 3mldz + h2o2 + nh4
1.4.3.4
monoamineoxidase(L-Normetanephrine)
Arginine and Proline Metabolism
[c] : h2o + normete-L + o2 --> 3m4hpga + h2o2 + nh4
1.5.1.12
L-4-hydroxyglutamatesemialdehydedehydrogenase,mitochondrial
Arginine and Proline Metabolism
[c] : 4hglusa + h2o + nad <==> e4hglu + 2 h + nadh
1.5.1.12
L-hydroxyprolinedehydrogenase(NADP),mitochondrial
Arginine and Proline Metabolism
[c] : 4hpro-LT + nadp --> 1p3h5c + 2 h + nadph
1.5.1.12
L-1-pyrroline-3-hydroxy-5-carboxylatedehydrogenase
Arginine and Proline Metabolism
[c] : 1p3h5c + 2 h2o + nad --> e4hglu + h + nadh
1.5.1.12
L-4-hydroxyglutamatesemialdehydedehydrogenase,mitochondrial
Arginine and Proline Metabolism
[c] : 4hglusa + h2o + nad <==> e4hglu + 2 h + nadh
1.5.1.12
D1-pyrroline-5-carboxylatedehydrogenase,mitochondrial Arginine and Proline Metabolism
[c] : glu5sa + h2o + nadp --> glu-L + 2 h + nadph
1.5.1.12
puta3
Arginine and Proline Metabolism
[c] : glu5sa + h2o + nad --> glu-L + 2 h + nadh
1.5.1.2
pyrroline-5-carboxylatereductase
Arginine and Proline Metabolism
[c] : 1pyr5c + 2 h + nadph --> nadp + pro-L
1.5.1.2
L-hydroxyprolinereductase(NADP)
Arginine and Proline Metabolism
[c] : 1p3h5c + 2 h + nadph --> 4hpro-LT + nadp
1.5.1.2
L-hydroxyprolinereductase(NAD)
Arginine and Proline Metabolism
[c] : 1p3h5c + 2 h + nadh --> 4hpro-LT + nad
1.5.1.2
pyrroline-5-carboxylatereductase(m)
Arginine and Proline Metabolism
[c] : 1pyr5c + 2 h + nadph --> nadp + pro-L
1.5.1.2
pyrroline-5-carboxylatereductase
Arginine and Proline Metabolism
[c] : 1pyr5c + 2 h + nadh --> nad + pro-L
1.5.1.2
prolineoxidase(L-proline,NAD)
Arginine and Proline Metabolism
[c] : nad + pro-L --> 1pyr5c + 2 h + nadh
or Chro.80098
6.1.1.15
Prolyl-tRNAsynthetase
Arginine and Proline Metabolism
[c] : atp + pro-L + trnapro --> amp + ppi + protrna
6.1.1.19
Arginyl-tRNAsynthetase
Arginine and Proline Metabolism
[c] : arg-L + atp + trnaarg --> amp + argtrna + ppi
2.2.1.7
_1-deoxy-D-xylulose5-phosphatesynthase
Biosynthesis of Steroids
[c] : g3p + h + pyr --> co2 + dxyl5p
2.7.1.148
_4-(cytidine5'-diphospho)-2-C-methyl-D-erythritolkinase Biosynthesis of Steroids
[c] : 4c2me + atp --> 2p4c2me + adp + h
2.7.7.60
_2-C-methyl-D-erythritol4-phosphatecytidylyltransferase Biosynthesis of Steroids
[c] : 2me4p + ctp + h --> 4c2me + ppi
6.3.4.15
biotin-[acetyl-CoA-carboxylase]ligase
Biotin Metabolism
[c] : atp + btn + h --> btamp + ppi
1.1.1.35
_3-hydroxyacyl-CoAdehydrogenase(acetoacetyl-CoA)
Butanoate Metabolism
[c] : aacoa + h + nadh <==> 3hbcoa + nad
1.1.1.35
_3-hydroxyacyl-CoAdehydrogenase(3-oxohexanoyl-CoA) Butanoate Metabolism
[c] : 3ohcoa + h + nadh <==> 3hhcoa + nad
1.1.1.35
_3-hydroxyacyl-CoAdehydrogenase(3-oxooctanoyl-CoA) Butanoate Metabolism
[c] : 3oocoa + h + nadh <==> 3hocoa + nad
1.1.1.35
_3-hydroxyacyl-CoAdehydrogenase(3-oxodecanoyl-CoA) Butanoate Metabolism
[c] : 3odcoa + h + nadh <==> 3hdcoa + nad
1.1.1.35
_3-hydroxyacyl-CoAdehydrogenase(3-oxododecanoyl-CoA)
Butanoate Metabolism
[c] : 3oddcoa + h + nadh <==> 3hddcoa + nad
1.1.1.35
_3-hydroxyacyl-CoAdehydrogenase(3-oxotetradecanoyl-CoA)
Butanoate Metabolism
[c] : 3otdcoa + h + nadh <==> 3htdcoa + nad
1.1.1.35
_3-hydroxyacyl-CoAdehydrogenase(3-oxohexadecanoyl-CoA)
Butanoate Metabolism
[c] : 3ohdcoa + h + nadh <==> 3hhdcoa + nad
2.7.2.3
phosphoglyceratekinase
Carbon Fixation
[c] : 3pg + atp <==> 13dpg + adp
5.3.1.6
ribose-5-phosphateisomerase
Carbon Fixation
[c] : r5p <==> ru5p-D
1.2.4.4
R_2_oxoisovalerate_dehydrogenase__acylating_4_methyl_2_oxopentaoate_
Cofactor and Prosthetic Group Biosynthesis[c] : 1.0 4mop + 1.0 coa + 1.0 nad <==> 1.0 co2 + 1.0 ivcoa + 1.0 nadh
4.6.1.12
_2-C-methyl-D-erythritol2,4-cyclodiphosphatesynthase Cofactor and Prosthetic Group Biosynthesis[c] : 2p4c2me --> 2mecdp + cmp
6.1.1.16
Cysteinyl-tRNAsynthetase
Cysteine Metabolism
[c] : atp + cys-L + trnacys --> amp + cystrna + ppi
or Chro.30258
2.3.1.39
Malonyl-CoA-ACPtransacylase
Fatty Acid Biosynthesis
[c] : ACP + malcoa <==> coa + malACP
2.3.1.41
R_b_ketoacyl_synthetase__n_C140_
Fatty Acid Biosynthesis
[c] : 1.0 accoa + 17.0 h + 6.0 malcoa + 12.0 nadph --> 6.0 co2 + 7.0 coa + 5.0 h2o + 12.0 nadp + 1
2.3.1.41
R_b_ketoacyl_synthetase__palmitate__n_C160_
Fatty Acid Biosynthesis
[c] : 1.0 accoa + 20.0 h + 7.0 malcoa + 14.0 nadph --> 7.0 co2 + 8.0 coa + 6.0 h2o + 1.0 hdca + 14
2.3.1.41
R_b_ketoacyl_synthetase__n_C180_
Fatty Acid Biosynthesis
[c] : 1.0 accoa + 23.0 h + 8.0 malcoa + 16.0 nadph --> 8.0 co2 + 9.0 coa + 7.0 h2o + 16.0 nadp + 1
2.3.1.41
R_b_ketoacyl_synthetase__n_C141_
Fatty Acid Biosynthesis
[c] : 1.0 accoa + 16.0 h + 6.0 malcoa + 11.0 nadph --> 6.0 co2 + 7.0 coa + 5.0 h2o + 11.0 nadp + 1
2.3.1.41
R_b_ketoacyl_synthetase__n_C161_
Fatty Acid Biosynthesis
[c] : 1.0 accoa + 19.0 h + 7.0 malcoa + 13.0 nadph --> 7.0 co2 + 8.0 coa + 6.0 h2o + 1.0 hdcea + 1
2.3.1.41
R_b_ketoacyl_synthetase__n_C181_
Fatty Acid Biosynthesis
[c] : 1.0 accoa + 22.0 h + 8.0 malcoa + 15.0 nadph --> 8.0 co2 + 9.0 coa + 7.0 h2o + 15.0 nadp + 1
2.3.1.41
R_b_ketoacyl_synthetase__branched(iso)_C100
Fatty Acid Biosynthesis
[c] : 8.0 h + 1.0 ibcoa + 3.0 malcoa + 6.0 nadph --> 3.0 co2 + 4.0 coa + 1.0 dca + 2.0 h2o + 6.0 na
2.3.1.41
R_b_ketoacyl_synthetase__branched(iso)_C130
Fatty Acid Biosynthesis
[c] : 11.0 h + 1.0 ivcoa + 4.0 malcoa + 8.0 nadph --> 4.0 co2 + 5.0 coa + 1.0 trdca + 3.0 h2o + 8.0
2.3.1.41
R_b_ketoacyl_synthetase__Iso_C140_
Fatty Acid Biosynthesis
[c] : 14.0 h + 1.0 ibcoa + 5.0 malcoa + 10.0 nadph --> 5.0 co2 + 6.0 coa + 1.0 fa1 + 4.0 h2o + 10.0
2.3.1.41
R_b_ketoacyl_synthetase__Iso_C150_
Fatty Acid Biosynthesis
[c] : 14.0 h + 1.0 ivcoa + 5.0 malcoa + 10.0 nadph --> 5.0 co2 + 6.0 coa + 1.0 fa3 + 4.0 h2o + 10.0
2.3.1.41
R_b_ketoacyl_synthetase__Iso_C160_
Fatty Acid Biosynthesis
[c] : 17.0 h + 1.0 ibcoa + 6.0 malcoa + 12.0 nadph --> 6.0 co2 + 7.0 coa + 1.0 fa6 + 5.0 h2o + 12.0
2.3.1.41
R_b_ketoacyl_synthetase__Iso_C170_
Fatty Acid Biosynthesis
[c] : 17.0 h + 1.0 ivcoa + 6.0 malcoa + 12.0 nadph --> 6.0 co2 + 7.0 coa + 1.0 fa11 + 5.0 h2o + 12.
2.3.1.41
R_b_ketoacyl_synthetase__Iso_C180_
Fatty Acid Biosynthesis
[c] : 20.0 h + 1.0 ibcoa + 7.0 malcoa + 14.0 nadph --> 7.0 co2 + 8.0 coa + 1.0 ocdcaiso + 6.0 h2o +
2.3.1.41
R_b_ketoacyl_synthetase__Iso_C161_
Fatty Acid Biosynthesis
[c] : 16.0 h + 1.0 ibcoa + 6.0 malcoa + 11.0 nadph --> 6.0 co2 + 7.0 coa + 1.0 fa5 + 5.0 h2o + 11.0
2.3.1.41
R_b_ketoacyl_synthetase__Iso_C171_
Fatty Acid Biosynthesis
[c] : 16.0 h + 1.0 ivcoa + 6.0 malcoa + 11.0 nadph --> 6.0 co2 + 7.0 coa + 1.0 fa9 + 5.0 h2o + 11.0
2.3.1.41
R_b_ketoacyl_synthetase__Anteiso_C150_
Fatty Acid Biosynthesis
[c] : 1.0 2mbcoa + 14.0 h + 5.0 malcoa + 10.0 nadph --> 5.0 co2 + 6.0 coa + 1.0 fa4 + 4.0 h2o + 10
2.3.1.41
R_b_ketoacyl_synthetase__Anteiso_C170_
Fatty Acid Biosynthesis
[c] : 1.0 2mbcoa + 17.0 h + 6.0 malcoa + 12.0 nadph --> 6.0 co2 + 7.0 coa + 1.0 fa12 + 5.0 h2o + 1
2.3.1.41
R_b_ketoacyl_synthetase__Anteiso_C171_
Fatty Acid Biosynthesis
[c] : 1.0 2mbcoa + 16.0 h + 6.0 malcoa + 11.0 nadph --> 6.0 co2 + 7.0 coa + 1.0 fa10 + 5.0 h2o + 1
or Chro.80198
1.1.1.1
alcoholdehydrogenase(glycerol)
Fatty Acid Metabolism
[c] : glyald + h + nadh <==> glyc + nad
or Chro.80198
1.1.1.1
_3,4-Dihydroxyphenylethyleneglycol:NAD+oxidoreductase
Fatty Acid Metabolism
[c] : 34dhmald + h + nadh <==> 34dhoxpeg + nad
1.14.14.1
cytochromeP450lanosterol14-alpha-demethylase(NADP) Fatty Acid Metabolism
[c] : 2 h + lanost + 3 nadph + 3 o2 --> 44mctr + for + 4 h2o + 3 nadp
1.14.14.1
Melatonin:NADPoxidoreductase
Fatty Acid Metabolism
[c] : h + melatn + nadph + o2 --> 6hoxmelatn + h2o + nadp
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : atp + coa + elaid <==> amp + od2coa + ppi
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : atp + coa + vacc <==> amp + ppi + vacccoa
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : atp + coa + ptdca <==> amp + ppi + ptdcacoa
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : atp + coa + eicostet <==> amp + eicostetcoa + ppi
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : atp + coa + lnlncg <==> amp + lnlncgcoa + ppi
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : atp + coa + lnlnca <==> amp + lnlncacoa + ppi
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : atp + coa + nrvnc <==> amp + nrvnccoa + ppi
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : atp + coa + hpdca <==> amp + hpdcacoa + ppi
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : atp + coa + tettet6 <==> amp + ppi + tettet6coa
or Chro.30084
6.2.1.3
fatty-acid--CoAligase(octadecynoate)
Fatty Acid Metabolism
[c] : atp + coa + ocdcya <==> amp + ocdycacoa + ppi
or Chro.30084
6.2.1.3
fatty-acid--CoAligase(octadecenoate)
Fatty Acid Metabolism
[c] : atp + coa + ocdcea <==> amp + odecoa + ppi
or Chro.30084
6.2.1.3
fatty-acid--CoAligase(octadecanoate)
Fatty Acid Metabolism
[c] : atp + coa + ocdca <==> amp + ppi + stcoa
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : atp + coa + strdnc <==> amp + ppi + strdnccoa
or Chro.30084
6.2.1.3
fatty-acid--CoAligase(tetradecenoate)
Fatty Acid Metabolism
[c] : atp + coa + ttdcea <==> amp + ppi + tdecoa
or Chro.30084
6.2.1.3
fatty-acid--CoAligase(tetradecanoate)
Fatty Acid Metabolism
[c] : atp + coa + ttdca <==> amp + ppi + tdcoa
or Chro.30084
6.2.1.3
C226fattyacidactivation
Fatty Acid Metabolism
[c] : atp + coa + crvnc --> amp + c226coa + ppi
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : atp + coa + lneldc <==> amp + lneldccoa + ppi
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : atp + coa + lnlc <==> amp + lnlccoa + ppi
or Chro.30084
6.2.1.3
fatty-acid--CoAligase(hexadecenoate)
Fatty Acid Metabolism
[c] : atp + coa + hdcea <==> amp + hdcoa + ppi
or Chro.30084
6.2.1.3
fatty-acid--CoAligase(hexadecanoate)
Fatty Acid Metabolism
[c] : atp + coa + hdca <==> amp + pmtcoa + ppi
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : arach + atp + coa <==> amp + arachcoa + ppi
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : atp + coa + dlnlcg <==> amp + dlnlcgcoa + ppi
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : arachd + atp + coa <==> amp + arachdcoa + ppi
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : atp + coa + tmndnc <==> amp + ppi + tmndnccoa
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : atp + coa + phyt <==> amp + phytcoa + ppi
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : atp + coa + crvnc <==> amp + c226coa + ppi
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : adrn + atp + coa <==> adrncoa + amp + ppi
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : atp + coa + lgnc <==> amp + lgnccoa + ppi
or Chro.30084
6.2.1.3
fatty-acid--CoAligase(n-C26:0)
Fatty Acid Metabolism
[c] : atp + coa + hexc <==> amp + hexccoa + ppi
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : atp + coa + tetpent3 <==> amp + ppi + tetpent3coa
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : atp + coa + tetpent6 <==> amp + ppi + tetpent6coa
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : atp + coa + prist --> amp + ppi + pristcoa
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : atp + coa + tethex3 <==> amp + ppi + tethex3coa
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : atp + coa + dcsptn1 <==> amp + dcsptn1coa + ppi
or Chro.30084
6.2.1.3
fatty-acid--CoAligase
Fatty Acid Metabolism
[c] : atp + clpnd + coa <==> amp + clpndcoa + ppi
1.5.1.3
dihydrofolatereductase
Folate-Vit B9 Metabolism
[c] : dhf + h + nadph <==> nadp + thf
1.5.1.3
folatereductase
Folate-Vit B9 Metabolism
[c] : fol + nadph --> dhf + nadp
3.1.3.1
alkalinephosphatase(Dihydroneopterin)
Folate-Vit B9 Metabolism
[c] : ahdt + 3 h2o --> dhnpt + 2 h + 3 pi
2.7.1.1
hexokinase(D-fructose:ATP)
Fructose and Mannose Metabolism
[c] : atp + fru --> adp + f6p + h
2.7.1.1
hexokinase(D-glucosamine:ATP)
Fructose and Mannose Metabolism
[c] : atp + gam --> adp + gam6p + h
2.7.1.105
_6-phosphofructo-2-kinase
Fructose and Mannose Metabolism
[c] : atp + f6p --> adp + f26bp + h
2.7.7.13
mannose-1-phosphateguanylyltransferase
Fructose and Mannose Metabolism
[c] : gtp + h + man1p --> gdpmann + ppi
2.7.7.22
mannose-1-phosphateguanylyltransferase(GDP)reversibleFructose and Mannose Metabolism
[c] : gdp + h + man1p <==> gdpmann + pi
4.1.2.13
D-Fructose1-phosphateD-glyceraldehyde-3-phosphate-lyase
Fructose and Mannose Metabolism
[c] : xu1p-D <==> dhap + gcald
4.1.2.13
D-Tagatose1-phosphateD-glyceraldehyde-3-phosphate-lyase
Fructose and Mannose Metabolism
[c] : tag1p-D <==> dhap + glyald

Appendix A: Metabolic Network Reactions included in the Model iNV213

R_FBA2
Chro.10335
R_FBA3
Chro.10335
R_TPI
Chro.10337
R_FCI
Chro.20165
R_MAN6PI
Chro.80224
R_PMANM
Chro.40115
R_MALT
Chro.30190
R_UDPG4E
Chro.40292
R_P5CD
Chro.60426
R_GLUTRS
Chro.60505
R_GLNTRS
Chro.10244
R_GMPS2
Chro.50499
R_G6PDH3
Chro.40088
R_G6PDH2r
Chro.40088
R_GTHP
Chro.30063
R_AMPTASECG
Chro.80395
R_G3PD1ir
Chro.20028
R_G3PD6
Chro.80050
R_G3PD7
Chro.80050
R_G3PD5
Chro.80050
R_GPAM_hs
Chro.60161
R_AGPAT1
Chro.80165
R_DAGK_SA
Chro.80280
R_DAGK_EC
Chro.80280
R_CHOLK
Chro.30240
R_ETHAK
Chro.50319
R_EPCTX
Chro.70332
R_CHLPCTD
Chro.80135
R_CPCTDTX
Chro.80135
R_DASYNm_SC
Chro.70059
R_DASYN_HP
Chro.70059
R_CDGGGS
Chro.70059
R_DASYN_TC
Chro.70059
R_CDSm
Chro.70059
R_DASYN_EC
Chro.70059
R_DASYN_SC
Chro.70059
R_DASYN_SA
Chro.70059
R_DASYNm_TC
Chro.70059
R_CDS
Chro.70059
R_ETHAPT_TC
Chro.40314
R_PEPT_EC
Chro.40314
R_ETHAPT_SC
Chro.40314
R_PEPT_HP
Chro.40314
R_PINOS_TC
Chro.80072
R_PGPPT
Chro.80072
R_PINOS_SC
Chro.80072
R_CDIPTr
Chro.80072
R_CDGGIPT
Chro.80072
R_PSSA1_hs
Chro.10133
R_PSSA_HP
Chro.10133
R_CDGGGSAT
Chro.10133
R_PSSA_SA
Chro.10133
R_PSSA2_hs
Chro.10133
R_PSERS_SC
Chro.10133
R_PSSA_EC
Chro.10133
R_LPS2
Chro.11000
R_LPS
Chro.11000
R_PLA2_2
.
R_ALKP
Chro.70170
R_PIPLCn
Chro.80452
R_GPDDA5
Chro.50344
R_GPDDA4
Chro.50344
R_GPDDA3
Chro.50344
R_GPDDA1
Chro.50344
R_GPDDA2
Chro.50344
R_PSD_EC
Chro.30247
R_PSD_HP
Chro.30247
R_PSD_SA
Chro.30247
R_G3PCT
.
R_CDGPT_CT
.
R_PGPPH_CT
.
R_PAP_CT
.
R_41R2A1H12BOOX Chro.21000
R_5HOXINOXDA
Chro.21000
R_3HXKYNOXDA
Chro.21000
R_5HXKYNOXDA
Chro.21000
R_41R1H2MAE12BOOX
Chro.21000
R_TRYPTAOX
Chro.21000
R_13DAMPPOX
Chro.80360
R_HISTASE
Chro.80360
R_42A12BOOX
Chro.80360
R_PTRCOX1
Chro.80360
R_TYROXDAc
Chro.80360
R_PEAMNO
Chro.80360
R_MAOX
Chro.80360
R_NMPTRCOX
Chro.80360
R_HSK
Chro.60426
R_PSP_L
Chro.70469
R_PSP_D
Chro.70469
R_SERTRS
Chro.80542
R_GLYTRS
Chro.80123
R_THRTRS
Chro.70201
R_ALCD2x
Chro.80199
R_GAPD
Chro.60434
R_HEX1
Chro.60435
R_PFKg
Chro.20231
R_GLUK
.
R_PYK
Chro.10234
R_PGKg
Chro.70113
R_ACYP
Chro.70488
R_PYRDC
Chro.70351
R_FBA
Chro.10335
R_ENO
Chro.50184
R_PGI
Chro.20336
R_PGM
Chro.10196
R_PGMT
Chro.20343
R_ACSm
Chro.10418
R_RBPC
Chro.20166
R_HISTRS
Chro.80461
R_PIN3K_SC
Chro.80217
R_PIK3
Chro.80217
R_PIN4K_SC
Chro.60392
R_PI4P5K_SC
Chro.20207
R_PI4P5K
Chro.20207
R_MI1345PP
Chro.50026
R_MI145PP
Chro.50026
R_PI45PLC
Chro.40288
R_PI45BPP_SC
Chro.40288
R_PIPLC
Chro.80452
R_AASAD3
Chro.40330
R_AASAD2
Chro.40330
R_AASAD1
Chro.40330

4.1.2.13
D-Fructose1-phosphateD-glyceraldehyde-3-phosphate-lyase
Fructose and Mannose Metabolism
[c] : f1p <==> dhap + glyald
4.1.2.13
Sedoheptulose1,7-bisphosphateD-glyceraldehyde-3-phosphate-lyase
Fructose and Mannose Metabolism
[c] : s17bp <==> dhap + e4p
5.3.1.1
triose-phosphateisomerase
Fructose and Mannose Metabolism
[c] : dhap <==> g3p
5.3.1.25
L-fucoseisomerase
Fructose and Mannose Metabolism
[c] : fuc-L <==> fcl-L
5.3.1.8
mannose-6-phosphateisomerase
Fructose and Mannose Metabolism
[c] : man6p <==> f6p
5.4.2.8
phosphomannomutase
Fructose and Mannose Metabolism
[c] : man1p <==> man6p
3.2.1.20
alpha-glucosidase
Galactose metabolism
[c] : h2o + malt --> 2 glc-D
5.1.3.2
UDPglucose4-epimerase
Galactose metabolism
[c] : udpg <==> udpgal
1.5.1.12
_1-pyrroline-5-carboxylatedehydrogenase
Glutamate metabolism
[c] : 1pyr5c + 2 h2o + nad --> glu-L + h + nadh
or Chro.80098 or Chro.10244
6.1.1.17
Glutamyl-tRNAsynthetase
Glutamate metabolism
[c] : atp + glu-L + trnaglu --> amp + glutrna + ppi
6.1.1.18
Glutaminyl-tRNAsynthetase
Glutamate metabolism
[c] : atp + gln-L + trnagln --> amp + glntrna + ppi
6.3.5.2
GMPsynthase
Glutamate metabolism
[c] : atp + gln-L + h2o + xmp --> amp + glu-L + gmp + 2 h + ppi
or Chro.60425
1.1.1.49
glucose6-phosphatedehydrogenase(F420-Dependent)
Glutathione Metabolism
[c] : f420-2 + g6p --> 6pgl + f420-2h2
or Chro.60425
1.1.1.49
glucose6-phosphatedehydrogenase
Glutathione Metabolism
[c] : g6p + nadp <==> 6pgl + h + nadph
1.11.1.9
glutathioneperidoxase
Glutathione Metabolism
[c] : 2 gthrd + h2o2 <==> gthox + 2 h2o
3.4.11.2
alanylaminopeptidase(cys-gly)
Glutathione Metabolism
[c] : cgly + h2o --> cys-L + gly
1.1.1.8
glycerol-3-phosphatedehydrogenase(NAD)
Glycerolipid Metabolism
[c] : dhap + h + nadh --> glyc3p + nad
1.1.99.5
glycerol-3-phosphatedehydrogenase(menaquinone-8)
Glycerolipid Metabolism
[c] : glyc3p + mqn8 --> dhap + mql8
1.1.99.5
glycerol-3-phosphatedehydrogenase(demethylmenaquinone-8)
Glycerolipid Metabolism
[c] : 2dmmq8 + glyc3p --> 2dmmql8 + dhap
1.1.99.5
glycerol-3-phosphatedehydrogenase(ubiquinone-8)
Glycerolipid Metabolism
[c] : glyc3p + q8 --> dhap + q8h2
2.3.1.15
glycerol-3-phosphateacyltransferase
Glycerolipid Metabolism
[c] : Rtotalcoa + glyc3p --> alpa_hs + coa
2.3.1.51
_1-acylglycerol-3-phosphateO-acyltransferase1
Glycerolipid Metabolism
[c] : Rtotal2coa + alpa_hs --> coa + pa_hs
2.7.1.107
Diacylglycerolkinase
Glycerolipid Metabolism
[c] : 0.02 12dgr_SA + atp --> adp + h + 0.02 pa_SA
2.7.1.107
Diacylglycerolkinase
Glycerolipid Metabolism
[c] : 0.02 12dgr_EC + atp --> adp + h + 0.02 pa_EC
2.7.1.32
Cholinekinase
Glycerolipid Metabolism
[c] : atp + chol --> adp + cholp + h
2.7.1.82
Ethanolaminekinase
Glycerolipid Metabolism
[c] : atp + etha --> adp + ethamp + h
2.7.7.14
ethanolamine-phosphatecytidylyltransferase
Glycerolipid Metabolism
[c] : 2ameph + ctp + h --> cmp2amep + ppi
2.7.7.15
cholinephosphatecytididyltransferase
Glycerolipid Metabolism
[c] : cholp + ctp + h --> cdpchol + ppi
2.7.7.15
choline-phosphatecytidylyltransferase
Glycerolipid Metabolism
[c] : ctp + h + ntm2amep --> cmpntm2amep + ppi
or Chro.20170
2.7.7.41
CDP-Diacylglycerolsynthetase,yeast-specific,mitochondrialGlycerolipid Metabolism
[c] : ctp + h + 0.01 pa_SC <==> 0.01 cdpdag_SC + ppi
or Chro.20170
2.7.7.41
CDP-DiacylglycerolsynthetaseHpspecific
Glycerolipid Metabolism
[c] : ctp + h + pa_Hp <==> cdpdag_HP + ppi
or Chro.20170
2.7.7.41
CDP-2,3-di-O-geranylgeranyl-sn-glycerolsynthase
Glycerolipid Metabolism
[c] : ctp + dgggp + h --> cdgggp + ppi
or Chro.20170
2.7.7.41
CDP-Diacylglycerolsynthetase,cruzi-specific
Glycerolipid Metabolism
[c] : ctp + h + 0.01 pa_TC <==> 0.01 cdpdag_TC + ppi
or Chro.20170
2.7.7.41
phosphatidatecytidylyltransferase
Glycerolipid Metabolism
[c] : ctp + h + pa_hs --> cdpdag_hs + ppi
or Chro.20170
2.7.7.41
CDP-Diacylglycerolsynthetase(Ecoli)
Glycerolipid Metabolism
[c] : ctp + h + 0.02 pa_EC <==> 0.02 cdpdag_EC + ppi
or Chro.20170
2.7.7.41
CDP-Diacylglycerolsynthetase,yeast-specific
Glycerolipid Metabolism
[c] : ctp + h + 0.01 pa_SC <==> 0.01 cdpdag_SC + ppi
or Chro.20170
2.7.7.41
CDP-Diacylglycerolsynthetase(Saureus)
Glycerolipid Metabolism
[c] : ctp + h + 0.02 pa_SA <==> 0.02 cdpdag_SA + ppi
or Chro.20170
2.7.7.41
CDP-Diacylglycerolsynthetase,cruzi-specific,mitochondrialGlycerolipid Metabolism
[c] : ctp + h + 0.01 pa_TC <==> 0.01 cdpdag_TC + ppi
or Chro.20170
2.7.7.41
phosphatidatecytidylyltransferase
Glycerolipid Metabolism
[c] : ctp + h + pa_hs --> cdpdag_hs + ppi
2.7.8.1
Ethanolaminephosphotransferase,cruzi-specific
Glycerolipid Metabolism
[c] : 0.01 12dgr_TC + cdpea <==> cmp + h + 0.01 pe_TC
2.7.8.1
ethanolaminephosphotransferase
Glycerolipid Metabolism
[c] : cmp + h + 0.02 pe_EC <==> 0.02 12dgr_EC + cdpea
2.7.8.1
Ethanolaminephosphotransferase,yeast-specific
Glycerolipid Metabolism
[c] : 0.01 12dgr_SC + cdpea <==> cmp + h + 0.01 pe_SC
2.7.8.1
ethanolaminephosphotransferase
Glycerolipid Metabolism
[c] : cmp + h + pe_HP <==> 12dgr_HP + cdpea
2.7.8.11
phosphatidylinositolsynthase,cruzi-specific
Glycerolipid Metabolism
[c] : 0.01 cdpdag_TC + inost --> cmp + h + 0.01 ptd1ino_TC
2.7.8.11
phosphatidyl-CMP:glycerophosphatephosphatidyltransferase
Glycerolipid Metabolism
[c] : cdpdag_hs + glyc3p --> cmp + h + pgp_hs
2.7.8.11
phosphatidylinositolsynthase,yeast-specific
Glycerolipid Metabolism
[c] : 0.01 cdpdag_SC + inost --> cmp + h + 0.01 ptd1ino_SC
2.7.8.11
phosphatidylinositolsynthase(Homosapiens)
Glycerolipid Metabolism
[c] : cdpdag_hs + inost <==> cmp + h + pail_hs
2.7.8.11
CDP-digeranyl-sn-glycero-myo-inositol3-phosphatidyltransferase
Glycerolipid Metabolism
[c] : cdgggp + inost --> cmp + dggpi + h
2.7.8.8
Phosphatidylserinesynthasehomosapiens
Glycerolipid Metabolism
[c] : pchol_hs + ser-L <==> chol + ps_hs
2.7.8.8
PhosphatidylserinesynthaseHpspecific
Glycerolipid Metabolism
[c] : cdpdag_HP + ser-L <==> cmp + h + ps_HP
2.7.8.8
CDP-2,3-di-O-geranylgeranyl-sn-glyceroserineO-archaetidyltransferase
Glycerolipid Metabolism
[c] : cdgggp + ser-L --> cmp + dgggps + h
2.7.8.8
Phosphatidylserinesyntase(Saureus)
Glycerolipid Metabolism
[c] : 0.02 cdpdag_SA + ser-L <==> cmp + h + 0.02 ps_SA
2.7.8.8
Phosphatidylserinesynthasehomosapiens
Glycerolipid Metabolism
[c] : pe_hs + ser-L <==> etha + ps_hs
2.7.8.8
phosphatidylserinesynthase,yeast-specific
Glycerolipid Metabolism
[c] : 0.01 cdpdag_SC + ser-L <==> cmp + h + 0.01 ps_SC
2.7.8.8
Phosphatidylserinesyntase(Ecoli)
Glycerolipid Metabolism
[c] : 0.02 cdpdag_EC + ser-L <==> cmp + h + 0.02 ps_EC
3.1.1.3
lipase
Glycerolipid Metabolism
[c] : dag_hs + h2o --> Rtotal + h + mag_hs
3.1.1.3
lipase
Glycerolipid Metabolism
[c] : h2o + tag_hs --> Rtotal3 + dag_hs + h
3.1.1.4
phospholipaseA2
Glycerolipid Metabolism
[c] : h2o + pchol_hs --> Rtotal2 + h + lpchol_hs
3.1.3.1
alkalinephosphatase
Glycerolipid Metabolism
[c] : dhap + h2o --> dha + pi
or Chro.20310 or Chro.40288
3.1.4.3
or Chro.20201
phosphatidylinositolphospholipaseC,nucleus
or Chro.30261
Glycerolipid Metabolism
[c] : h2o + pail_hs --> dag_hs + h + mi1p-D
or Chro.40291
3.1.4.46
Glycerophosphodiesterphosphodiesterase(Glycerophosphoinositol)
Glycerolipid Metabolism
[c] : g3pi + h2o --> glyc3p + h + inost
or Chro.40291
3.1.4.46
Glycerophosphodiesterphosphodiesterase(Glycerophosphoglycerol)
Glycerolipid Metabolism
[c] : g3pg + h2o --> glyc + glyc3p + h
or Chro.40291
3.1.4.46
Glycerophosphodiesterphosphodiesterase(Glycerophosphoserine)
Glycerolipid Metabolism
[c] : g3ps + h2o --> glyc3p + h + ser-L
or Chro.40291
3.1.4.46
Glycerophosphodiesterphosphodiesterase(Glycerophosphocholine)
Glycerolipid Metabolism
[c] : g3pc + h2o --> chol + glyc3p + h
or Chro.40291
3.1.4.46
Glycerophosphodiesterphosphodiesterase(Glycerophosphoethanolamine)
Glycerolipid Metabolism
[c] : g3pe + h2o --> etha + glyc3p + h
4.1.1.65
Phosphatidylserinedecarboxylase(Ecoli)
Glycerolipid Metabolism
[c] : h + 0.02 ps_EC --> co2 + 0.02 pe_EC
4.1.1.65
PhosphatidylserinedecarboxylaseHpspecific
Glycerolipid Metabolism
[c] : h + ps_HP --> co2 + pe_HP
4.1.1.65
Phosphatidylserinedecarboxylase(Saureus)
Glycerolipid Metabolism
[c] : h + 0.02 ps_SA --> co2 + 0.02 pe_SA
2.7.7.39
R_glycerol_3_phosphate_cytidylyltransferase
Glycerophospholipid Metabolism
[c] : 1.0 ctp + 1.0 glyc3p + 1.0 h --> 1.0 cdpglyc + 1.0 ppi
2.7.8.5
R_CDPdiacylglycerolsn_glycerol_3_phosphate_3_phosphatidyltransferase
Glycerophospholipid Metabolism
[c] : 1.0 cdpdag_CT + 1.0 glyc3p --> 1.0 cmp + 1.0 h + 1.0 pglyp_CT
3.1.3.27
R_Phosphatidylglycerophosphate_phosphohydrolase
Glycerophospholipid Metabolism
[c] : 1.0 h2o + 1.0 pglyp_CT --> 1.0 pgly_CT + 1.0 pi
3.1.3.4
R_phosphatidic_acid_phosphatase
Glycerophospholipid Metabolism
[c] : 1.0 12dag3p_CT + 1.0 h2o --> 1.0 12dgr_CT + 1.0 pi
1.4.3.4
_4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol:oxygenoxidoreductase(deaminating)(flavin-containing)
Glycine, Serine, and Threonine Metabolism[c] : h2o + nrpphr + o2 --> 34dhmald + h2o2 + nh4
1.4.3.4
_5-Hydroxytryptamine:oxygenoxidoreductase(deaminating)(flavin-containing)
Glycine, Serine, and Threonine Metabolism[c] : h2o + o2 + srtn --> 5hoxindact + h2o2 + nh4
1.4.3.4
_3-Hydroxykynurenamine:oxygenoxidoreductase(deaminating)(flavin-containing)
Glycine, Serine, and Threonine Metabolism[c] : 3hxkynam + o2 --> 48dhoxquin + h2o2 + nh4
1.4.3.4
_5-Hydroxykynurenamine:oxygenoxidoreductase(deaminating)(flavin-containing)
Glycine, Serine, and Threonine Metabolism[c] : 5hxkynam + o2 --> 46dhoxquin + h2o2 + nh4
1.4.3.4
_4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol:oxygenoxidoreductase(deaminating)(flavin-containing)
Glycine, Serine, and Threonine Metabolism[c] : adrnl + h2o + o2 --> 34dhmald + h2o2 + mma
1.4.3.4
Tryptamine:oxygenoxidoreductase(deaminating)(flavin-containing)
Glycine, Serine, and Threonine Metabolism[c] : h2o + o2 + trypta --> h2o2 + id3acald + nh4
or Chro.30388
1.4.3.6
_1,3-Diaminopropane:oxygenoxidoreductase(deaminating)
Glycine, Serine, and Threonine Metabolism[c] : 13dampp + h2o + o2 --> bamppald + h2o2 + nh4
or Chro.30388
1.4.3.6
Histaminase
Glycine, Serine, and Threonine Metabolism[c] : h2o + hista + o2 --> h2o2 + im4act + nh4
or Chro.30388
1.4.3.6
_4-(2-Aminoethyl)-1,2-benzenediol:oxygenoxidoreductase(deaminating)(flavin-containing)
Glycine, Serine, and Threonine Metabolism[c] : dopa + h2o + o2 --> 34dhpac + h2o2 + nh4
or Chro.30388
1.4.3.6
Putrescine:oxygenoxidoreductase(deaminating)
Glycine, Serine, and Threonine Metabolism[c] : h2o + o2 + ptrc --> 4abutn + h2o2 + nh4
or Chro.30388
1.4.3.6
Tyramine:oxygenoxidoreductase(deaminating)(flavin-containing)(cytosol)
Glycine, Serine, and Threonine Metabolism[c] : h2o + o2 + tym --> 4hoxpacd + h2o2 + nh4
or Chro.30388
1.4.3.6
Phenethylamineoxidase
Glycine, Serine, and Threonine Metabolism[c] : h2o + o2 + peamn --> h2o2 + nh4 + pacald
or Chro.30388
1.4.3.6
Methylamineoxidase
Glycine, Serine, and Threonine Metabolism[c] : h2o + mma + o2 --> fald + h2o2 + nh4
or Chro.30388
1.4.3.6
N-Methylputrescine:oxygenoxidoreductase(deaminating) Glycine, Serine, and Threonine Metabolism[c] : nmptrc + o2 --> 1mpyr + h2o2 + nh4
2.7.1.39
homoserinekinase
Glycine, Serine, and Threonine Metabolism[c] : atp + hom-L --> adp + h + phom
3.1.3.3
phosphoserinephosphatase(L-serine)
Glycine, Serine, and Threonine Metabolism[c] : h2o + pser-L --> pi + ser-L
3.1.3.3
phosphoserinephosphatase(D-serine)
Glycine, Serine, and Threonine Metabolism[c] : h2o + pser-D --> pi + ser-D
6.1.1.11
Seryl-tRNAsynthetase
Glycine, Serine, and Threonine Metabolism[c] : atp + ser-L + trnaser --> amp + ppi + sertrna
6.1.1.14
Glycyl-tRNAsynthetase
Glycine, Serine, and Threonine Metabolism[c] : atp + gly + trnagly --> amp + glytrna + ppi
6.1.1.3
Threonyl-tRNAsynthetase
Glycine, Serine, and Threonine Metabolism[c] : atp + thr-L + trnathr --> amp + ppi + thrtrna
or Chro.80198
1.1.1.1
alcoholdehydrogenase(ethanol)
Glycolysis/Gluconeogenesis
[c] : etoh + nad <==> acald + h + nadh
or Chro.10337
1.2.1.12
glyceraldehyde-3-phosphatedehydrogenase
Glycolysis/Gluconeogenesis
[c] : g3p + nad + pi <==> 13dpg + h + nadh
2.7.1.1
hexokinase
Glycolysis/Gluconeogenesis
[c] : atp + glc-D --> adp + h + g6p
or Chro.30172
2.7.1.11
phosphofructokinase,glycosome
Glycolysis/Gluconeogenesis
[c] : atp + f6p --> adp + fdp + h
2.7.1.2
Glucokinase
Glycolysis/Gluconeogenesis
[c] : atp + glc-D --> adp + g6p-B + h
2.7.1.40
pyruvatekinase
Glycolysis/Gluconeogenesis
[c] : adp + h + pep --> atp + pyr
2.7.2.3
phosphoglyceratekinase
Glycolysis/Gluconeogenesis
[c] : 3pg + atp <==> 13dpg + adp
3.6.1.7
acylphosphatase
Glycolysis/Gluconeogenesis
[c] : 13dpg + h2o --> 3pg + h + pi
4.1.1.1
pyruvatedecarboxylase
Glycolysis/Gluconeogenesis
[c] : h + pyr --> acald + co2
4.1.2.13
fructose-bisphosphatealdolase
Glycolysis/Gluconeogenesis
[c] : fdp <==> dhap + g3p
4.2.1.11
enolase
Glycolysis/Gluconeogenesis
[c] : 2pg <==> h2o + pep
5.3.1.9
glucose-6-phosphateisomerase
Glycolysis/Gluconeogenesis
[c] : g6p <==> f6p
or Chro.70471
5.4.2.1
phosphoglyceratemutase
Glycolysis/Gluconeogenesis
[c] : 2pg <==> 3pg
5.4.2.2
phosphoglucomutase
Glycolysis/Gluconeogenesis
[c] : g1p <==> g6p
6.2.1.1
acetyl-CoAsynthetase
Glycolysis/Gluconeogenesis
[c] : ac + atp + coa --> accoa + amp + ppi
4.1.1.39
ribulose-bisphosphatecarboxylase
Glyoxylate and dicarboxylate Metabolism [c] : co2 + h2o + rb15bp --> 2 3pg + 2 h
6.1.1.21
Histidyl-tRNAsynthetase
Histidine Metabolism
[c] : atp + his-L + trnahis --> amp + histrna + ppi
or Chro.60213
2.7.1.137
_1-phosphatidylinositol3-kinase,yeast-specific
Inositol Phosphate Metabolism
[c] : atp + 0.01 ptd1ino_SC --> adp + h + 0.01 ptd3ino_SC
or Chro.60213
2.7.1.137
phosphatidylinositol3-kinase
Inositol Phosphate Metabolism
[c] : atp + pail_hs --> adp + h + pail3p_hs
or Chro.80518
2.7.1.67
phosphatidylinositol4-kinase,yeast-specific
Inositol Phosphate Metabolism
[c] : atp + 0.01 ptd1ino_SC --> adp + h + 0.01 ptd4ino_SC
2.7.1.68
phosphatidylinositol-4-phosphate5-kinase,yeast-specfic Inositol Phosphate Metabolism
[c] : atp + 0.01 ptd4ino_SC --> adp + h + 0.01 ptd145bp_SC
2.7.1.68
phosphatidylinositol4-phosphate5-kinase
Inositol Phosphate Metabolism
[c] : atp + pail4p_hs --> adp + h + pail45p_hs
3.1.3.56
inositol-1,3,4,5-trisphosphate5-phosphatase
Inositol Phosphate Metabolism
[c] : h2o + mi1345p --> mi134p + pi
3.1.3.56
inositol-1,4,5-trisphosphate5-phosphatase
Inositol Phosphate Metabolism
[c] : h2o + mi145p --> mi14p + pi
3.1.4.11
phosphatidylinositol4,5-bisphosphatephospholipaseC
Inositol Phosphate Metabolism
[c] : h2o + pail45p_hs --> dag_hs + h + mi145p
3.1.4.11
_1-phosphatidylinositol-4,5-bisphosphatephosphodiesterase,yeast-specific
Inositol Phosphate Metabolism
[c] : h2o + 0.01 ptd145bp_SC --> 0.01 12dgr_SC + h + mi145p
or Chro.20310 or Chro.40288
3.1.4.3
or Chro.20201
phosphatidylinositolphospholipaseC
or Chro.30261
Inositol Phosphate Metabolism
[c] : h2o + pail_hs --> dag_hs + h + mi1p-D
1.2.1.31
L-aminoadipate-semialdehydedehydrogenase(NADH)
Lysine Biosynthesis
[c] : L2aadp6sa + h2o + nad --> L2aadp + 2 h + nadh
1.2.1.31
L-aminoadipate-semialdehydedehydrogenase(NADH)
Lysine Biosynthesis
[c] : L2aadp + atp + h + nadh --> L2aadp6sa + amp + nad + ppi
1.2.1.31
L-aminoadipate-semialdehydedehydrogenase(NADPH)
Lysine Biosynthesis
[c] : L2aadp + atp + h + nadph --> L2aadp6sa + amp + nadp + ppi

Appendix A: Metabolic Network Reactions included in the Model iNV213

R_LYSTRS
Chro.40267
6.1.1.6
R_LYSMTF2
Chro.40051
2.1.1.43
R_LYSMTF3
Chro.40051
2.1.1.43
R_LYSMTF1
Chro.40051
2.1.1.43
R_PRDX
Chro.40093 or Chro.80075 or Chro.30063
1.11.1.7
R_GHMT3
Chro.80302 or Chro.80306
2.1.2.1
R_GHMT2r
Chro.80302 or Chro.80306
2.1.2.1
R_DNAMT
Chro.50169
2.1.1.37
R_DNAMTSE
Chro.50169
2.1.1.37
R_METAT
Chro.70301
2.5.1.6
R_AHC
Chro.30017
3.3.1.1
R_METTRS
Chro.80398
6.1.1.10
R_G3POA_CT
.
.
R_LYSLG_CT
.
.
R_UGT_CT
.
.
R_UGT1_CT
.
.
R_UGT2_CT
.
.
R_LIPO1S24_CT
.
.
R_LIPO2S24_CT
.
.
R_LIPO3S24_CT
.
.
R_LIPO4S24_CT
.
.
R_TECA1S45
.
.
R_TECA2S45
.
.
R_TECA3S45
.
.
R_TECA4S_CT
.
.
R_TEICH45
.
.
R_UAGPT3
.
.
R_PPTGS_CT
.
.
R_FRTT
.
.
R_GGTT
.
.
R_PPTT
.
.
R_HEXTT
.
.
R_ICHORS
.
.
R_2S6HCCi
.
.
R_SUCBZS
.
.
R_SUCBZL
.
.
R_NPHS
.
.
R_DHNAOT7
.
.
R_AMMQT7
.
.
R_H2CO3D2
.
.
R_IPDPS
1.17.1.2
R_MECDPDH
.
1.17.4.3
R_AGPATr_CT
Chro.80165
2.3.1.51
R_DAGK_CT
Chro.40493
2.7.1.107
R_PHCYT_CT
Chro.70332
2.7.7.41
R_CLPNS2_CT
.
2.7.8.R_CDPDSP_CT
Chro.10133
2.7.8.8
R_PSDC_CT
Chro.30247
4.1.1.65
R_FACOAL100
Chro.50052 or Chro.30084
6.2.1.3
R_FACOAL130
Chro.50052 or Chro.30084
6.2.1.3
R_FACOAL140_ISO_ Chro.50052 or Chro.30084
6.2.1.3
R_FACOAL150_anteiso_
Chro.50052 or Chro.30084
6.2.1.3
R_FACOAL150_ISO_ Chro.50052 or Chro.30084
6.2.1.3
R_FACOAL160_ISO_ Chro.50052 or Chro.30084
6.2.1.3
R_FACOAL161_ISO_ Chro.50052 or Chro.30084
6.2.1.3
R_FACOAL170_anteiso_
Chro.50052 or Chro.30084
6.2.1.3
R_FACOAL170_ISO_ Chro.50052 or Chro.30084
6.2.1.3
R_FACOAL171_anteiso_
Chro.50052 or Chro.30084
6.2.1.3
R_FACOAL171_ISO_ Chro.50052 or Chro.30084
6.2.1.3
R_FACOAL180_ISO_ Chro.50052 or Chro.30084
6.2.1.3
R_THD2
Chro.80274
1.6.1.1
R_NADTRHD
Chro.10120
1.6.1.2
R_NADK
Chro.80231
2.7.1.23
R_UDPDOLPT_U
Chro.50118
2.4.1.117
R_UDPDOLPT_L
Chro.50118
2.4.1.117
R_DOLASNT_Uer
Chro.20179 or Chro.60585
2.4.1.119
R_DOLASNT_Ler
Chro.20179 or Chro.60585
2.4.1.119
R_DOLPMT_L
Chro.50175
2.4.1.83
R_DOLPMT_U
Chro.50175
2.4.1.83
R_DOLPMTcer
Chro.50175
2.4.1.83
R_DOLK
Chro.20170
2.7.1.108
R_DOLK_U
Chro.20170
2.7.1.108
R_DOLK_L
Chro.20170
2.7.1.108
R_GLCNACPT_L
Chro.50156
2.7.8.15
R_GLCNACPT_U
Chro.50156
2.7.8.15
R_HCO3E
Chro.40064
4.2.1.1
R_H2CO3D
Chro.40064
4.2.1.1
R_ASNS2
Chro.50501
6.3.1.1
R_GLNS
Chro.60524
6.3.1.2
R_ASNS1
Chro.30020
6.3.5.4
R_G1PTT
Chro.80452
2.7.7.24
R_TDPGDH
Chro.20206
4.2.1.46
R_GALNT
Chro.60231 or Chro.50322 or Chro.70157
2.4.1.41
R_NADH10
Chro.70218
1.6.5.3
R_ECHH_1_PERIOD_0Chro.70218
1.6.5.3
R_NADH5
Chro.70218
1.6.5.3
R_NADH7
Chro.70218
1.6.5.3
R_NADH6
Chro.70218
1.6.5.3
R_NADH9
Chro.70218
1.6.5.3
R_NADH8
Chro.70218
1.6.5.3
R_NADH2_DASH_u6cm
Chro.70218
1.6.99.3
R_CYOO_HP
Chro.70168
1.9.3.1
R_PPA_1
Chro.40159
3.6.1.1
R_PPA2
Chro.40159
3.6.1.1
R_PPA
Chro.40159
3.6.1.1
R_ATPS4r
Chro.60082 and Chro.20424 and
3.6.3.14
Chro.80551
R_ATPasel
Chro.60082 and Chro.20424 and
3.6.3.14
Chro.80551
R_ATPS
Chro.20424 and Chro.70559 and
3.6.3.6
Chro.50302
R_CAATPS
Chro.20424 and Chro.70559 and
3.6.3.6
Chro.50302
R_ATPS1
Chro.20424 and Chro.70559 and
3.6.3.6
Chro.50302
R_DPCOAK
Chro.20045
2.7.1.24
R_PNTK
Chro.70552 or Chro.80038
2.7.1.33
R_PFK_2
Chro.20231
2.7.1.11
R_PFK_3
Chro.20231
2.7.1.11
R_PFK
Chro.20231
2.7.1.11
R_G6PI2
Chro.20336
5.3.1.9
R_G6PI
Chro.20336
5.3.1.9
R_SHKK
Chro.30373
2.7.1.71
R_DHQD
Chro.80609
4.2.1.10
R_TRPS3
Chro.50503
4.2.1.20
R_TRPS2
Chro.50503
4.2.1.20
R_TRPS1
Chro.50503
4.2.1.20
R_TYRTRS
Chro.40444 or Chro.60344
6.1.1.1
R_PHETRS
Chro.30378 or Chro.80385
6.1.1.20
R_UPP3S
.
4.2.1.75
R_GLUTRS_LPAREN_Gln_RPAREN_
Chro.60505 or Chro.80098 or Chro.10244
6.1.1.17
R_ACOAD3
Chro.31000 or Chro.41000
1.3.99.3
R_ACOAD5
Chro.31000 or Chro.41000
1.3.99.3
R_ACOAD4
Chro.31000 or Chro.41000
1.3.99.3
R_ACOAD7
Chro.31000 or Chro.41000
1.3.99.3
R_ACOAD6
Chro.31000 or Chro.41000
1.3.99.3
R_ACOAD2
Chro.31000 or Chro.41000
1.3.99.3

Lysyl-tRNAsynthetase
Lysine Biosynthesis
[c] : atp + lys-L + trnalys --> amp + lystrna + ppi
histone-lysineN-methyltransferase,nuclear
Lysine Degradation
[c] : Nmelys + amet --> Ndmelys + ahcys
histone-lysineN-methyltransferase,nuclear
Lysine Degradation
[c] : Ndmelys + amet --> Ntmelys + ahcys
histone-lysineN-methyltransferase,nuclear
Lysine Degradation
[c] : amet + peplys --> Nmelys + ahcys
Peroxidase(multiplesubstrates)
Methane Metabolism
[c] : h2o2 + meoh --> fald + 2 h2o
glycinehydroxymethyltransferase
Methane Metabolism
[c] : 3htmelys + h --> 4tmeabut + gly
glycinehydroxymethyltransferase,reversible
Methane Metabolism
[c] : ser-L + thf <==> gly + h2o + mlthf
DNA(cytosine-5-)-methyltransferase,nucleus
Methionine Metabolism
[c] : amet + dna --> ahcys + dna5mtc + h
DNA(cytosine-5-)-methyltransferase,nucleus
Methionine Metabolism
[c] : dna + seasmet --> dna5mtc + h + seahcys
methionineadenosyltransferase
Methionine Metabolism
[c] : atp + h2o + met-L --> amet + pi + ppi
adenosylhomocysteinase
Methionine Metabolism
[c] : ahcys + h2o <==> adn + hcys-L
Methionyl-tRNAsynthetase
Methionine Metabolism
[c] : atp + met-L + trnamet --> amp + mettrna + ppi
R_glycerol_3_phosphate_O_acyltransferase
Miscellaneous
[c] : 1.0 glyc3p + 0.051 dcacoa + 0.022 trdacoa + 0.023 fa1coa + 0.0092 tdcoa + 0.022 ttdcecoa + 0
R_lysylphosphatidylglycerol_synthesis
Miscellaneous
[c] : 1.0 atp + 1.0 lys-L + 1.0 pgly_CT --> 1.0 amp + 1.0 h + 1.0 lysylpgly_CT + 1.0 ppi
R_UDP_glucosyltransferase__diglucosyl_
Miscellaneous
[c] : 1.0 12dgr_CT + 2.0 udpg --> 1.0 d12dg_CT + 2.0 h + 2.0 udp
R_UDP_glucosyltransferase__monoglucosyl_
Miscellaneous
[c] : 1.0 12dgr_CT + 1.0 udpg --> 1.0 h + 1.0 m12dg_CT + 1.0 udp
R_UDP_glucosyltransferase__triglucosyl_
Miscellaneous
[c] : 1.0 12dgr_CT + 3.0 udpg --> 3.0 h + 1.0 t12dg_CT + 3.0 udp
R_lipoteichoic_acid_synthesis__n24___linked__glucose_substituted
Miscellaneous
[c] : 24.0 cdpglyc + 1.0 d12dg_CT + 24.0 udpg --> 24.0 cmp + 48.0 h + 1.0 lipo1_24_CT + 24.0 udp
R_lipoteichoic_acid_synthesis__n24___linked__N_acetylglucosamine_substituted
Miscellaneous
[c] : 24.0 cdpglyc + 1.0 d12dg_CT + 24.0 uacgam --> 24.0 cmp + 48.0 h + 1.0 lipo2_24_CT + 24.0 u
R_lipoteichoic_acid_synthesis__n24___unliked__D_alanine_substituted
Miscellaneous
[c] : 24.0 ala-D + 24.0 atp + 24.0 cdpglyc + 1.0 d12dg_CT + 24.0 h2o --> 24.0 amp + 24.0 cmp + 4
R_lipoteichoic_acid_synthesis__n24___linked__unsubstituted
Miscellaneous
[c] : 24.0 cdpglyc + 1.0 d12dg_CT --> 24.0 cmp + 24.0 h + 1.0 lipo4_24_CT
R_glycerol_teichoic_acid__n45___unlinked__unsubstituted
Miscellaneous
[c] : 45.0 cdpglyc + 1.0 uacgam + 1.0 uacmam --> 45.0 cmp + 1.0 gtca1_45_CT + 46.0 h + 1.0 udp
R_glycerol_teichoic_acid__n45___unlinked__D_ala_substituted
Miscellaneous
[c] : 45.0 ala-D + 45.0 atp + 45.0 cdpglyc + 45.0 h2o + 1.0 uacgam + 1.0 uacmam --> 45.0 amp + 4
R_glycerol_teichoic_acid__n45___unlinked__glucose_substituted
Miscellaneous
[c] : 45.0 cdpglyc + 1.0 h2o + 1.0 uacgam + 1.0 uacmam + 45.0 udpg --> 45.0 cmp + 1.0 gtca3_45_
R_minor_teichoic_acid_synthesis__n30_
Miscellaneous
[c] : 30.0 h2o + 30.0 uacgala + 30.0 udpg --> 60.0 h + 1.0 tcam_CT + 30.0 udp + 30.0 ump
R_teichuronic_acid__n45___unlinked__GalNAc_GlcA_repeated
Miscellaneous
[c] : 45.0 uacgala + 45.0 udpglcur <==> 45.0 h + 1.0 teich_45_CT + 45.0 udp + 45.0 ump
R_UDP_N_acetylglucosamine_N_acetylmuramyl__pentapeptide_pyrophosphoryl_undecaprenol_N_acetylglucosamine_transferase
Miscellaneous
[c] : 1.0 uacgam + 1.0 uagmda --> 1.0 h + 1.0 uaagmda + 1.0 udp
R_Peptidoglycan_subunit_synthesis
Miscellaneous
[c] : 1.0 uaagmda --> 1.0 h + 1.0 peptido_CT + 1.0 udcpdp
R_farnesyltranstransferase
Miscellaneous
[c] : 1.0 frdp + 1.0 ipdp --> 1.0 ggdp + 1.0 ppi
R_geranylgeranyltranstransferase
Miscellaneous
[c] : 1.0 ggdp + 1.0 ipdp --> 1.0 pendp + 1.0 ppi
R_trans_pentaprenyltranstransferase
Miscellaneous
[c] : 1.0 ipdp + 1.0 pendp --> 1.0 hexdp + 1.0 ppi
R_trans_hexaprenyltranstransferase
Miscellaneous
[c] : 1.0 hexdp + 1.0 ipdp --> 1.0 hepdp + 1.0 ppi
R_isochorismate_synthase
Miscellaneous
[c] : 1.0 chor <==> 1.0 ichor
R_2_succinyl_6_hydroxy_2_4_cyclohexadiene_1_carboxylate_synthase
Miscellaneous
[c] : 1.0 akg + 1.0 h + 1.0 ichor --> 1.0 2shchc + 1.0 co2 + 1.0 pyr
R_O_succinylbenzoate_CoA_synthase
Miscellaneous
[c] : 1.0 2shchc --> 1.0 h2o + 1.0 sucbz
R_o_succinylbenzoate_CoA_ligase
Miscellaneous
[c] : 1.0 atp + 1.0 coa + 1.0 sucbz --> 1.0 amp + 1.0 ppi + 1.0 sbzcoa
R_naphthoate_synthase
Miscellaneous
[c] : 1.0 sbzcoa --> 1.0 coa + 1.0 dhna
R_1_4_dihydroxy_2_naphthoate_octaprenyltransferase Miscellaneous
[c] : 1.0 dhna + 1.0 hepdp + 1.0 nad --> 1.0 2dmmq7 + 1.0 co2 + 1.0 nadh + 1.0 ppi
R_S_adenosylmethione2_demthylmenaquinone_methyltransferase__menaquinone_7_
Miscellaneous
[c] : 1.0 2dmmq7 + 1.0 amet + 1.0 nadph --> 1.0 ahcys + 1.0 mql7 + 1.0 nadp
carboxylicaciddissociation
Miscellaneous
[c] : h + hco3 <==> h2co3
_1-hydroxy-2-methyl-2-(E)-butenyl4-diphosphatereductase(ipdp)
Miscellaneous
[c] : h + h2mb4p + nadh --> h2o + ipdp + nad
_2C-methyl-D-erythritol2,4cyclodiphosphatedehydratase Miscellaneous
[c] : 2mecdp + h --> h2mb4p + h2o
R_1_acylglycerol_3_phosphate_O_acyltransferase
Miscellaneous
[c] : 1.0 1ag3p_CT + 0.051 dcacoa + 0.022 trdacoa + 0.023 fa1coa + 0.0092 tdcoa + 0.022 ttdcecoa
R_diacylglycerol_kinase
Miscellaneous
[c] : 1.0 12dgr_CT + 1.0 atp --> 1.0 12dag3p_CT + 1.0 adp + 1.0 h
R_phosphatidate_cytidylyltransferase
Miscellaneous
[c] : 1.0 12dag3p_CT + 1.0 ctp + 1.0 h --> 1.0 cdpdag_CT + 1.0 ppi
R_cardiolipin_synthase
Miscellaneous
[c] : 2.0 pgly_CT --> 1.0 cdlp_CT + 1.0 glyc
R_CDPdiacylglycerol_serine_O_phosphatidyltransferase Miscellaneous
[c] : 1.0 cdpdag_CT + 1.0 ser-L --> 1.0 cmp + 1.0 h + 1.0 ps_CT
R_phosphatidylserine_decarboxylase
Miscellaneous
[c] : 1.0 ps_CT --> 1.0 co2 + 1.0 psetha_CT
R_fatty_acid__CoA_ligase__Iso_C100_
Miscellaneous
[c] : 1.0 atp + 1.0 coa + 1.0 dca <==> 1.0 amp + 1.0 dcacoa + 1.0 ppi
R_fatty_acid__CoA_ligase__Iso_C130_
Miscellaneous
[c] : 1.0 atp + 1.0 coa + 1.0 trdca <==> 1.0 amp + 1.0 trdacoa + 1.0 ppi
R_fatty_acid__CoA_ligase__Iso_C140_
Miscellaneous
[c] : 1.0 atp + 1.0 coa + 1.0 fa1 <==> 1.0 amp + 1.0 fa1coa + 1.0 ppi
R_fatty_acid__CoA_ligase__anteiso_C150_
Miscellaneous
[c] : 1.0 atp + 1.0 coa + 1.0 fa4 <==> 1.0 amp + 1.0 fa4coa + 1.0 ppi
R_fatty_acid__CoA_ligase__Iso_C150_
Miscellaneous
[c] : 1.0 atp + 1.0 coa + 1.0 fa3 <==> 1.0 amp + 1.0 fa3coa + 1.0 ppi
R_fatty_acid__CoA_ligase__Iso_C160_
Miscellaneous
[c] : 1.0 atp + 1.0 coa + 1.0 fa6 <==> 1.0 amp + 1.0 fa6coa + 1.0 ppi
R_fatty_acid__CoA_ligase__Iso_C161_
Miscellaneous
[c] : 1.0 atp + 1.0 coa + 1.0 fa5 <==> 1.0 amp + 1.0 fa5coa + 1.0 ppi
R_fatty_acid__CoA_ligase__anteiso_C170_
Miscellaneous
[c] : 1.0 atp + 1.0 coa + 1.0 fa12 <==> 1.0 amp + 1.0 fa12coa + 1.0 ppi
R_fatty_acid__CoA_ligase__Iso_C170_
Miscellaneous
[c] : 1.0 atp + 1.0 coa + 1.0 fa11 <==> 1.0 amp + 1.0 fa11coa + 1.0 ppi
R_fatty_acid__CoA_ligase__anteiso_C171_
Miscellaneous
[c] : 1.0 atp + 1.0 coa + 1.0 fa10 <==> 1.0 amp + 1.0 fa10coa + 1.0 ppi
R_fatty_acid__CoA_ligase__Iso_C171_
Miscellaneous
[c] : 1.0 atp + 1.0 coa + 1.0 fa9 <==> 1.0 amp + 1.0 fa9coa + 1.0 ppi
R_fatty_acid__CoA_ligase__Iso_C180_
Miscellaneous
[c] : 1.0 atp + 1.0 coa + 1.0 ocdcaiso <==> 1.0 amp + 1.0 ppi + 1.0 strcoaiso
NAD(P)transhydrogenase
NAD Metabolism
2 h[e] + nadh[c] + nadp[c] --> 2 h[c] + nad[c] + nadph[c]
NADtranshydrogenase
NAD Metabolism
[c] : nad + nadph --> nadh + nadp
NADkinase
NAD Metabolism
[c] : atp + nad --> adp + h + nadp
UDPglucose:dolichyl-phosphatebeta-D-glucosyltransferase(uterus)
N-Glycan Biosynthesis
[c] : 0.1 dolp_U + udpg --> 0.1 dolglcp_U + udp
UDPglucose:dolichyl-phosphatebeta-D-glucosyltransferase(liver)
N-Glycan Biosynthesis
[c] : 0.1 dolp_L + udpg --> 0.1 dolglcp_L + udp
Dolichyl-diphosphooligosaccharide:protein-L-asparagineoligopolysaccharidotransferase(uterus)
N-Glycan Biosynthesis
[c] : Asn-X_DASH_Ser_FSLASH_Thr + 0.1 g3m8mpdol_U --> 0.1 doldp_U + g3m8masn + h
Dolichyl-diphosphooligosaccharide:protein-L-asparagineoligopolysaccharidotransferase(liver)
N-Glycan Biosynthesis
[c] : Asn-X_DASH_Ser_FSLASH_Thr + 0.1 g3m8mpdol_L --> 0.1 doldp_L + g3m8masn + h
Dolichyl-phosphateD-mannosyltransferase(liver)
N-Glycan Biosynthesis
[c] : 0.1 dolp_L + gdpmann --> 0.1 dolmanp_L + gdp
Dolichyl-phosphateD-mannosyltransferase(uterus)
N-Glycan Biosynthesis
[c] : 0.1 dolp_U + gdpmann --> 0.1 dolmanp_U + gdp
Dolichyl-phosphateD-mannosyltransferase
N-Glycan Biosynthesis
dolp[c] + gdpmann[c] --> dolmanp[r] + gdp[c]
Dolicholkinase
N-Glycan Biosynthesis
[c] : ctp + dolichol --> cdp + dolp + h
Dolicholkinase,human(uterus)
N-Glycan Biosynthesis
[c] : ctp + 0.1 dolichol_U --> cdp + 0.1 dolp_U + h
Dolicholkinase,human(liver)
N-Glycan Biosynthesis
[c] : ctp + 0.1 dolichol_L --> cdp + 0.1 dolp_L + h
UDP-GlcNAc:dolichol-phosphateGlcNAcphosphotransferase(liver)
N-Glycan Biosynthesis
[c] : 0.1 dolp_L + uacgam --> 0.1 naglc2p_L + ump
UDP-GlcNAc:dolichol-phosphateGlcNAcphosphotransferase(uterus)
N-Glycan Biosynthesis
[c] : 0.1 dolp_U + uacgam --> 0.1 naglc2p_U + ump
HCO3equilibrationreaction
Nitrogen Metabolism
[c] : co2 + h2o <==> h + hco3
carboxylicaciddissociation
Nitrogen Metabolism
[c] : co2 + h2o <==> h2co3
asparaginesynthetase
Nitrogen Metabolism
[c] : asp-L + atp + nh4 --> amp + asn-L + h + ppi
glutaminesynthetase
Nitrogen Metabolism
[c] : atp + glu-L + nh4 --> adp + gln-L + h + pi
asparaginesynthase(glutamine-hydrolysing)
Nitrogen Metabolism
[c] : asp-L + atp + gln-L + h2o --> amp + asn-L + glu-L + h + ppi
glucose-1-phosphatethymidylyltransferase
Nucleotide Sugar Metabolism
[c] : dttp + g1p + h --> dtdpglu + ppi
dTDPglucose4,6-dehydratase
Nucleotide Sugar Metabolism
[c] : dtdpglu --> dtdp4d6dg + h2o
GalNActransferase,Golgiapparatus
O-Glycan Biosynthesis
[c] : Ser_FSLASH_Thr + udpacgal --> Tn_antigen + h + udp
NADHdehydrogenase(menaquinone-8&0protons)
Oxidative Phosphorylation
[c] : h + mqn8 + nadh --> mql8 + nad
EchHydrogenase
Oxidative Phosphorylation
2 fdred[c] + 3 h[c] <==> 2 fdox[c] + h[e] + h2[c]
NADHdehydrogenase(ubiquinone-8)
Oxidative Phosphorylation
[c] : h + nadh + q8 --> nad + q8h2
NADHdehydrogenase(menaquinone-8&2protons)
Oxidative Phosphorylation
3 h[c] + mqn8[c] + nadh[c] --> 2 h[e] + mql8[c] + nad[c]
NADHdehydrogenase(ubiquinone-8&3.5protons)
Oxidative Phosphorylation
4.5 h[c] + nadh[c] + q8[c] --> 3.5 h[e] + nad[c] + q8h2[c]
NADHdehydrogenase(demethylmenaquinone-8&0protons)Oxidative Phosphorylation
[c] : 2dmmq8 + h + nadh --> 2dmmql8 + nad
NADHdehydrogenase(demethylmenaquinone-8&2.8protons)
Oxidative Phosphorylation
2dmmq8[c] + 3.8 h[c] + nadh[c] --> 2dmmql8[c] + 2.8 h[e] + nad[c]
NADHdehydrogenase,cytosolic/mitochondrial
Oxidative Phosphorylation
h[c] + nadh[c] + q6[c] --> nad[c] + q6h2[c]
cytochromec553oxidase,Hpylori
Oxidative Phosphorylation
4 focytcc553[c] + 5.98 h[c] + o2[c] --> 4 ficytcc553[c] + 2 h[e] + 1.99 h2o[c] + 0.005 o2s[c]
inorganicdiphosphatase(oneprotontranslocation)
Oxidative Phosphorylation
h2o[c] + ppi[c] --> h[e] + 2 pi[c]
inorganictriphosphatase
Oxidative Phosphorylation
[c] : h2o + pppi --> h + pi + ppi
inorganicdiphosphatase
Oxidative Phosphorylation
[c] : h2o + ppi --> h + 2 pi
ATPsynthase(fourprotonsforoneATP)
and Chro.70559 and Chro.50340 and Chro.50039 and Chro.10063
Oxidative and
Phosphorylation
Chro.10062 and Chro.50302adp[c]
and Chro.80195
+ 4 h[e] +and
pi[c]
Chro.80048
<==> atp[c]
and+Chro.40070
3 h[c] + h2o[c]
and Chro.20149 and Chro.20148
V-typeATPase,H+transporting,lysosomal
and Chro.70559 and Chro.50340 and Chro.50039 and Chro.10063
Oxidative and
Phosphorylation
Chro.10062 and Chro.50302atp[c]
and Chro.80195
+ 3 h[c] + and
h2o[c]
Chro.80048
--> adp[c]
and
+ Chro.40070
4 h[l] + pi[c]and Chro.20149 and Chro.20148
ATPase,cytosolic
and Chro.80195 and Chro.80048 and Chro.40070 and Chro.20149
Oxidative and
Phosphorylation
Chro.20148
atp[c] + h2o[c] --> adp[c] + h[e] + pi[c]
CaATPase
and Chro.80195 and Chro.80048 and Chro.40070 and Chro.20149
Oxidative and
Phosphorylation
Chro.20148
atp[c] + 2 ca2[c] + h2o[c] --> adp[c] + 2 ca2[e] + h[e] + pi[c]
H+-exportingATPase
and Chro.80195 and Chro.80048 and Chro.40070 and Chro.20149
Oxidative and
Phosphorylation
Chro.20148
atp[c] + h[c] + h2o[c] --> adp[c] + 2 h[e] + pi[c]
dephospho-CoAkinase
Pantothenate-Vit B5 and CoA biosynthesis [c] : atp + dpcoa --> adp + coa + h
pantothenatekinase
Pantothenate-Vit B5 and CoA biosynthesis [c] : atp + pnto-R --> 4ppan + adp + h
Phosphofructokinase
Pentose Phosphate Pathway
[c] : atp + tag6p-D --> adp + h + tagdp-D
phosphofructokinase(s7p)
Pentose Phosphate Pathway
[c] : atp + s7p --> adp + h + s17bp
phosphofructokinase
Pentose Phosphate Pathway
[c] : atp + f6p --> adp + fdp + h
Glucose-6-phosphateisomerase
Pentose Phosphate Pathway
[c] : g6p-B <==> f6p-B
Glucose-6-phosphateisomerase
Pentose Phosphate Pathway
[c] : g6p <==> g6p-B
shikimatekinase
Phenylalanine, Tyrosine and Tryptophan Biosynthesis
[c] : atp + skm --> adp + h + skm5p
_3-dehydroquinatedehydratase
Phenylalanine, Tyrosine and Tryptophan Biosynthesis
[c] : 3dhq <==> 3dhsk + h2o
tryptophansynthase(indoleglycerolphosphate)
Phenylalanine, Tyrosine and Tryptophan Biosynthesis
[c] : 3ig3p --> g3p + indole
tryptophansynthase(indole)
Phenylalanine, Tyrosine and Tryptophan Biosynthesis
[c] : indole + ser-L --> h2o + trp-L
tryptophansynthase(indoleglycerolphosphate)
Phenylalanine, Tyrosine and Tryptophan Biosynthesis
[c] : 3ig3p + ser-L --> g3p + h2o + trp-L
tyrosyl-tRNAsynthetase
Phenylalanine, Tyrosine and Tryptophan Biosynthesis
[c] : atp + trnatyr + tyr-L --> amp + ppi + tyrtrna
Phenylalanyl-tRNAsynthetase
Phenylalanine, Tyrosine and Tryptophan Biosynthesis
[c] : atp + phe-L + trnaphe --> amp + phetrna + ppi
uroporphyrinogen-IIIsynthase
Porphyrin and chlorophyll metabolism
[c] : hmbil --> h2o + uppg3
Glutamyl-tRNAsynthetase(Gln)
Porphyrin and chlorophyll metabolism
[c] : atp + glu-L + trnagln --> amp + glutrna_LPAREN_gln_RPAREN_ + ppi
acyl-CoAdehydrogenase(octanoyl-CoA)
Propanoate Metabolism
[c] : nad + occoa <==> h + nadh + oc2coa
acyl-CoAdehydrogenase(dodecanoyl-CoA)
Propanoate Metabolism
[c] : ddcacoa + nad <==> dd2coa + h + nadh
acyl-CoAdehydrogenase(decanoyl-CoA)
Propanoate Metabolism
[c] : dcacoa + nad <==> dc2coa + h + nadh
acyl-CoAdehydrogenase(hexadecanoyl-CoA)
Propanoate Metabolism
[c] : nad + pmtcoa --> h + hdd2coa + nadh
acyl-CoAdehydrogenase(tetradecanoyl-CoA)
Propanoate Metabolism
[c] : nad + tdcoa <==> h + nadh + td2coa
acyl-CoAdehydrogenase(hexanoyl-CoA)
Propanoate Metabolism
[c] : h + hx2coa + nadh <==> hxcoa + nad

Appendix A: Metabolic Network Reactions included in the Model iNV213

R_ACCOACr
R_IMPD
R_RNDR2n
R_RNDR4n
R_ADNK2
R_ADNK1
R_ADK2
R_NDPK10
R_NDPK9
R_NDPK8
R_NDPK7
R_NDPK6
R_NDPK5
R_NDPK4
R_NDPK3
R_NDPK2
R_NDPK1
R_DGK1
R_GK1
R_NTD11
R_NTD10
R_NTD12
R_NTD9
R_NTD8
R_NTD1
R_NTD3
R_NTD2
R_NTD5
R_NTD4
R_NTD7
R_NTD6
R_NT5C
R_PDE1
R_PDE2
R_PDE3
R_PDE5
R_PDE4
R_AMPDAm
R_AMPDAg
R_NTPP9
R_NTPP10
R_NTPP11
R_UTPH2e
R_GTPH2e
R_ATPH2e
R_UTPH1e
R_GTPH1e
R_ATPH1e
R_NDP3ex
R_NDP10ex
R_NDP4
R_NDP6
R_NDP3
R_NDP8
R_NDP8ex
R_NDP3g
R_NDP7er
R_NDP7ex
R_NDP7g
R_ADSL2r
R_ADSL1r
R_ADSL2
R_ADSL1
R_ADNCYC
R_GUACYC
R_GMPS
R_RNDR4
R_RNDR3
R_RNDR1
R_RNDR2
R_TRDR
R_TRDR2
R_TRDR3
R_TMDS
R_TMDSf
R_UPPRTr
R_TMDK1
R_URIK2
R_URIK1
R_CYTK2
R_UMPK5
R_CYTK9
R_CYTK8
R_CYTK5
R_CYTK7
R_CYTK6
R_CYTK1
R_UMPK3
R_UMPK2
R_UMPK7
R_UMPK6
R_UMPK4
R_CYTK11
R_CYTK10
R_CYTK13
R_CYTK12
R_CYTK14
R_UMPK
R_DTMPK
R_DUMPK
R_DCMPDA
R_DCYTD
R_AP4AH1
R_DUTPDP
R_YUMPS
R_CBPS
R_LDH_L
R_MCLOR
R_2HBO
R_MDH
R_MDHi2
R_ME1
R_ME2
R_MDH2
R_MDH3
R_MDH4
R_ACALD
R_PDH
R_ACYP_2
R_PPC
R_ACS2
R_ACS

Chro.80425
Chro.60012
Chro.60090
Chro.60090
Chro.20322
Chro.20322
Chro.50037
Chro.40275
Chro.40275
Chro.40275
Chro.40275
Chro.40275
Chro.40275
Chro.40275
Chro.40275
Chro.40275
Chro.40275
Chro.70250
Chro.70250
Chro.50026
Chro.50026
Chro.50026
Chro.50026
Chro.50026
Chro.50026
Chro.50026
Chro.50026
Chro.50026
Chro.50026
Chro.50026
Chro.50026
Chro.50026
Chro.30269
Chro.30269
Chro.30269
Chro.30269
Chro.30269
Chro.40214
Chro.40214
Chro.10434
Chro.10434
Chro.10434
Chro.60194
Chro.60194
Chro.60194
Chro.60194
Chro.60194
Chro.60194
Chro.60194
Chro.60194
Chro.60194
Chro.60194
Chro.60194
Chro.60194
Chro.60194
Chro.60194
Chro.60194
Chro.60194
Chro.60194
.
.
.
.
Chro.50255
Chro.50255
.
Chro.60090
Chro.60090
Chro.60090
Chro.60090
Chro.20464
Chro.20464
Chro.20464
Chro.40506
Chro.40506
Chro.10216
Chro.50398
Chro.10216
Chro.10216
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Chro.50490
Chro.50490
Chro.20294
Chro.20294
.
Chro.70577
Chro.20165
.
Chro.70063
Chro.70063
Chro.70063
Chro.70063
Chro.70063
Chro.50314
Chro.50314
Chro.80050
Chro.80050
Chro.80050
Chro.80198
Chro.40087
Chro.70488
Chro.50389
Chro.10418
Chro.10418

or Chro.60091
or Chro.60091

or
or
or
or
or
or
or
or
or
or

Chro.50237
Chro.50237
Chro.50237
Chro.50237
Chro.50237
Chro.50237
Chro.50237
Chro.50237
Chro.50237
Chro.50237

or
or
or
or
or

Chro.60462
Chro.60462
Chro.60462
Chro.60462
Chro.60462

or
or
or
or
or
or
or
or
or
or

or Chro.70577
or Chro.70577
or Chro.70577

or Chro.40352
or Chro.30141 or
or
or
or
or

Chro.60091
Chro.60091
Chro.60091
Chro.60091

or Chro.30116
or Chro.30116
or Chro.70052
or Chro.20045 or
or Chro.20045 or

or Chro.30435 or

or
or
or
or

Chro.70062
Chro.70062
Chro.70062
Chro.70062

6.4.1.2
acetyl-CoAcarboxylase,reversiblereaction
1.1.1.205
IMPdehydrogenase
1.17.4.1
ribonucleoside-diphosphatereductase(GDP),nuclear
1.17.4.1
ribonucleoside-diphosphatereductase(UDP),nuclear
2.7.1.20
adenosinekinase
2.7.1.20
adenosinekinase
2.7.4.3
adenylatekinase(Inorganictriphosphate)
Chro.40219
2.7.4.6
nucleoside-diphosphatekinase(ATP:dIDP)
Chro.40219
2.7.4.6
nucleoside-diphosphatekinase(ATP:IDP)
Chro.40219
2.7.4.6
nucleoside-diphosphatekinase(ATP:dADP)
Chro.40219
2.7.4.6
nucleoside-diphosphatekinase(ATP:dCDP)
Chro.40219
2.7.4.6
nucleoside-diphosphatekinase(ATP:dUDP)
Chro.40219
2.7.4.6
nucleoside-diphosphatekinase(ATP:dGDP)
Chro.40219
2.7.4.6
nucleoside-diphosphatekinase(ATP:dTDP)
Chro.40219
2.7.4.6
nucleoside-diphosphatekinase(ATP:CDP)
Chro.40219
2.7.4.6
nucleoside-diphosphatekinase(ATP:UDP)
Chro.40219
2.7.4.6
nucleoside-diphosphatekinase(ATP:GDP)
2.7.4.8
deoxyguanylatekinase(dGMP:ATP)
2.7.4.8
guanylatekinase(GMP:ATP)
3.1.3.5
_5'-nucleotidase(IMP)
3.1.3.5
_5'-nucleotidase(XMP)
3.1.3.5
_5'-nucleotidase(dIMP)
3.1.3.5
_5'-nucleotidase(GMP)
3.1.3.5
_5'-nucleotidase(dGMP)
3.1.3.5
_5'-nucleotidase(dUMP)
3.1.3.5
_5'-nucleotidase(dCMP)
3.1.3.5
_5'-nucleotidase(UMP)
3.1.3.5
_5'-nucleotidase(dTMP)
3.1.3.5
_5'-nucleotidase(CMP)
3.1.3.5
_5'-nucleotidase(AMP)
3.1.3.5
_5'-nucleotidase(dAMP)
3.1.3.5
_5'-nucleotidase
3.1.4.17
_3',5'-cyclic-nucleotidephosphodiesterase
3.1.4.17
_3',5'-cyclic-nucleotidephosphodiesterase
3.1.4.17
_3',5'-cyclic-nucleotidephosphodiesterase
3.1.4.17
_3',5'-cyclic-nucleotidephosphodiesterase
3.1.4.17
_3',5'-cyclic-nucleotidephosphodiesterase
3.5.4.6
Adenosinemonophosphatedeaminase,mitochondrion
3.5.4.6
Adenosinemonophosphatedeaminase,glycosome
3.6.1.19
Nucleosidetriphosphatepyrophosphorylase(itp)
3.6.1.19
Nucleosidetriphosphatepyrophosphorylase(ditp)
3.6.1.19
Nucleosidetriphosphatepyrophosphorylase(xtp)
3.6.1.5
UTPdiphosphohydrolase
3.6.1.5
GTPdiphosphohydrolase
3.6.1.5
ATPdiphosphohydrolase
3.6.1.5
UTPdiphosphohydrolase
3.6.1.5
GTPdiphosphohydrolase
3.6.1.5
ATPdiphosphohydrolase
3.6.1.6
nucleoside-diphosphatase(GDP),extracellular
3.6.1.6
nucleoside-diphosphatase(IDP),extracellular
3.6.1.6
nucleoside-diphosphatase(dGDP)
3.6.1.6
nucleoside-diphosphatase(dCDP)
3.6.1.6
nucleoside-diphosphatase(GDP)
3.6.1.6
nucleoside-diphosphatase(dUDP)
3.6.1.6
nucleoside-diphosphatase(UTP),extracellular
3.6.1.6
nucleoside-diphosphatase(GDP),Golgi
3.6.1.6
nucleoside-diphosphatase(UDP),endoplasmicreticulum
3.6.1.6
nucleoside-diphosphatase(UDP),extracellular
3.6.1.6
nucleoside-diphosphatase(UDP),Golgiapparatus
4.3.2.2
adenylosuccinatelyase
4.3.2.2
adenylsuccinatelyase
4.3.2.2
adenylosuccinatelyase
4.3.2.2
adenylosuccinatelyase
4.6.1.1
adenylatecyclase
Chro.30329
4.6.1.2
or Chro.40352
guanylatecyclase
6.3.4.1
GMPsynthase
1.17.4.1
ribonucleoside-diphosphatereductase(UDP)
1.17.4.1
ribonucleoside-diphosphatereductase(CDP)
1.17.4.1
ribonucleoside-diphosphatereductase(ADP)
1.17.4.1
ribonucleoside-diphosphatereductase(GDP)
1.8.1.9
thioredoxinreductase(NADPH)
1.8.1.9
Thioredoxin(ubiquinone10)reductase(NADPH)
1.8.1.9
Thioredoxin(ubiquinone10)reductase(NADH)
2.1.1.45
thymidylatesynthase
2.1.1.45
thymidylatesynthase(Flavin-dependent)
2.4.2.9
uracilphosphoribosyltransferase(r)
2.7.1.21
thymidinekinase(ATP:thymidine)
Chro.80328
2.7.1.48
uridinekinase(GTP:Uridine)
Chro.80328
2.7.1.48
uridinekinase(ATP:Uridine)
2.7.4.14
cytidylatekinase(dCMP)
2.7.4.14
UMPkinase(dATP)
2.7.4.14
cytidylatekinase(CMP,dCTP)
2.7.4.14
cytidylatekinase(CMP,dATP)
2.7.4.14
cytidylatekinase(dCMP)
2.7.4.14
cytidylatekinase(CMP,UTP)
2.7.4.14
cytidylatekinase(CMP,CTP)
2.7.4.14
cytidylatekinase(CMP)
2.7.4.14
UMPkinase(UTP)
2.7.4.14
UMPkinase(CTP)
2.7.4.14
UMPkinase(dGTP)
2.7.4.14
UMPkinase(dCTP)
2.7.4.14
UMPkinase(GTP)
2.7.4.14
cytidylatekinase(dCMP,dGTP)
2.7.4.14
cytidylatekinase(CMP,dGTP)
2.7.4.14
cytidylatekinase(dCMP,dATP)
2.7.4.14
cytidylatekinase(dCMP,dCTP)
2.7.4.14
cytidylatekinase(dCMP,UTP)
2.7.4.14
UMPkinase
2.7.4.9
dTMPkinase
2.7.4.9
dUMPkinase
3.5.4.12
dCMPdeaminase
3.5.4.14
deoxycytidinedeaminase
3.6.1.17
Ap4Ahydrolase,asymmetrically
3.6.1.23
dUTPdiphosphatase
Chro.20259
4.2.1.70
or Chro.80065
yUMPsynthetase
or Chro.80602
6.3.5.5
carbamoyl-phosphatesynthase(glutamine-hydrolysing)
1.1.1.27
L-lactatedehydrogenase
1.1.1.27
_3-Mercaptolactate:NAD+oxidoreductase
1.1.1.27
_2-Hydroxybutyrate:NAD+oxidoreductase
1.1.1.37
malatedehydrogenase
1.1.1.37
malatedehydrogenase(otherdirection)
1.1.1.38
malicenzyme(NAD)
1.1.1.40
malicenzyme(NADP)
1.1.99.16
Malatedehydrogenase(ubiquinone8asacceptor)
1.1.99.16
Malatedehydrogenase(menaquinone8asacceptor)
1.1.99.16
Malatedehydrogenase(menaquinone6asacceptor)
1.2.1.10
acetaldehydedehydrogenase(acetylating)
1.2.1.51
pyruvatedehydrogenase
3.6.1.7
acylphosphatase(2)
4.1.1.31
phosphoenolpyruvatecarboxylase
6.2.1.1
acetyl-CoAsynthase(propionate)
6.2.1.1
acetyl-CoAsynthetase

Propanoate Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyruvate Metabolism
Pyruvate Metabolism
Pyruvate Metabolism
Pyruvate Metabolism
Pyruvate Metabolism
Pyruvate Metabolism
Pyruvate Metabolism
Pyruvate Metabolism
Pyruvate Metabolism
Pyruvate Metabolism
Pyruvate Metabolism
Pyruvate Metabolism
Pyruvate Metabolism
Pyruvate Metabolism
Pyruvate Metabolism
Pyruvate Metabolism

[c] : accoa + atp + hco3 <==> adp + h + malcoa + pi
[c] : h2o + imp + nad --> h + nadh + xmp
[c] : gdp + trdrd --> dgdp + h2o + trdox
[c] : trdrd + udp --> dudp + h2o + trdox
[c] : adn + gtp --> adp + gmp + h
[c] : adn + atp --> adp + amp + h
[c] : amp + pppi <==> adp + ppi
[c] : atp + didp <==> adp + ditp
[c] : atp + idp <==> adp + itp
[c] : atp + dadp <==> adp + datp
[c] : atp + dcdp <==> adp + dctp
[c] : atp + dudp <==> adp + dutp
[c] : atp + dgdp <==> adp + dgtp
[c] : atp + dtdp <==> adp + dttp
[c] : atp + cdp <==> adp + ctp
[c] : atp + udp <==> adp + utp
[c] : atp + gdp <==> adp + gtp
[c] : atp + dgmp <==> adp + dgdp
[c] : atp + gmp <==> adp + gdp
[c] : h2o + imp --> ins + pi
[c] : h2o + xmp --> pi + xtsn
[c] : dimp + h2o --> din + pi
[c] : gmp + h2o --> gsn + pi
[c] : dgmp + h2o --> dgsn + pi
[c] : dump + h2o --> duri + pi
[c] : dcmp + h2o --> dcyt + pi
[c] : h2o + ump --> pi + uri
[c] : dtmp + h2o --> pi + thymd
[c] : cmp + h2o --> cytd + pi
[c] : amp + h2o --> adn + pi
[c] : damp + h2o --> dad-2 + pi
[c] : h2o + nicrnt --> nicrns + pi
[c] : camp + h2o --> amp + h
[c] : 35cdamp + h2o --> damp + h
[c] : 35cimp + h2o --> h + imp
[c] : 35ccmp + h2o --> cmp + h
[c] : 35cgmp + h2o --> gmp + h
[c] : amp + h + h2o --> imp + nh4
[c] : amp + h + h2o --> imp + nh4
[c] : h2o + itp --> h + imp + ppi
[c] : ditp + h2o --> dimp + h + ppi
[c] : h2o + xtp --> h + ppi + xmp
[e] : udp + h2o --> ump + h + pi
[e] : gdp + h2o --> gmp + h + pi
[e] : adp + h2o --> amp + h + pi
[e] : utp + 2 h2o --> ump + 2 h + 2 pi
[e] : gtp + 2 h2o --> gmp + 2 h + 2 pi
[e] : atp + 2 h2o --> amp + 2 h + 2 pi
[e] : gdp + h2o --> gmp + h + pi
[e] : h2o + idp --> h + imp + pi
[c] : dgdp + h2o --> dgmp + h + pi
[c] : dcdp + h2o --> dcmp + h + pi
[c] : gdp + h2o --> gmp + h + pi
[c] : dudp + h2o --> dump + h + pi
[e] : h2o + utp --> h + pi + udp
[c] : gdp + h2o --> gmp + h + pi
[c] : h2o + udp --> h + pi + ump
[e] : h2o + udp --> h + pi + ump
[c] : h2o + udp --> h + pi + ump
[c] : 25aics <==> aicar + fum
[c] : dcamp <==> amp + fum
[c] : 25aics --> aicar + fum
[c] : dcamp --> amp + fum
[c] : atp --> camp + ppi
[c] : gtp --> 35cgmp + ppi
[c] : atp + nh4 + xmp --> amp + gmp + 2 h + ppi
[c] : trdrd + udp --> dudp + h2o + trdox
[c] : cdp + trdrd --> dcdp + h2o + trdox
[c] : adp + trdrd --> dadp + h2o + trdox
[c] : gdp + trdrd --> dgdp + h2o + trdox
[c] : h + nadph + trdox --> nadp + trdrd
[c] : h + nadph + q10 --> nadp + q10h2
[c] : h + nadh + q10 --> nad + q10h2
[c] : dump + mlthf --> dhf + dtmp
[c] : dump + fmnh2 + mlthf --> dtmp + fmn + thf
[c] : prpp + ura <==> ppi + ump
[c] : atp + thymd --> adp + dtmp + h
[c] : gtp + uri --> gdp + h + ump
[c] : atp + uri --> adp + h + ump
[c] : atp + dcmp <==> adp + dcdp
[c] : datp + ump <==> dadp + udp
[c] : cmp + dctp <==> cdp + dcdp
[c] : cmp + datp <==> cdp + dadp
[c] : ctp + dcmp <==> cdp + dcdp
[c] : cmp + utp <==> cdp + udp
[c] : cmp + ctp <==> 2 cdp
[c] : atp + cmp <==> adp + cdp
[c] : ump + utp <==> 2 udp
[c] : ctp + ump <==> cdp + udp
[c] : dgtp + ump <==> dgdp + udp
[c] : dctp + ump <==> dcdp + udp
[c] : gtp + ump <==> gdp + udp
[c] : dcmp + dgtp <==> dcdp + dgdp
[c] : cmp + dgtp <==> cdp + dgdp
[c] : datp + dcmp <==> dadp + dcdp
[c] : dcmp + dctp <==> 2 dcdp
[c] : dcmp + utp <==> dcdp + udp
[c] : atp + ump <==> adp + udp
[c] : atp + dtmp <==> adp + dtdp
[c] : atp + dump <==> adp + dudp
[c] : dcmp + h + h2o <==> dump + nh4
[c] : dcyt + h + h2o --> duri + nh4
[c] : ap4a + h2o --> amp + atp + 2 h
[c] : dutp + h2o --> dump + h + ppi
[c] : r5p + ura <==> h2o + psd5p
[c] : 2 atp + gln-L + h2o + hco3 --> 2 adp + cbp + glu-L + 2 h + pi
[c] : lac-L + nad <==> h + nadh + pyr
[c] : mercplac + nad <==> h + mercppyr + nadh
[c] : 2hb + nad <==> 2obut + h + nadh
[c] : mal-L + nad <==> h + nadh + oaa
[c] : h + nadh + oaa --> mal-L + nad
[c] : mal-L + nad --> co2 + nadh + pyr
[c] : mal-L + nadp --> co2 + nadph + pyr
[c] : mal-L + q8 --> oaa + q8h2
[c] : mal-L + mqn8 --> mql8 + oaa
[c] : mal-L + mqn6 --> mql6 + oaa
[c] : acald + coa + nad <==> accoa + h + nadh
[c] : coa + nadp + pyr --> accoa + co2 + nadph
[c] : actp + h2o --> ac + h + pi
[c] : co2 + h2o + pep --> h + oaa + pi
[c] : atp + coa + ppa --> amp + ppcoa + ppi
[c] : ac + atp + coa --> accoa + amp + ppi

Appendix A: Metabolic Network Reactions included in the Model iNV213

R_RDH3a
Chro.40258
R_RDH1a
Chro.40258
R_RDH2a
Chro.40258
R_RDH1
Chro.40258
R_RDH3
Chro.40258
R_RDH2
Chro.40258
R_RDH4
Chro.40258
R_RBFSb
Chro.80106
R_RBFSa
Chro.80106
R_ACP1_LPAREN_FMN_RPAREN_
Chro.20071
R_SULR
Chro.40087
R_SEAHCYSHYD
Chro.30017
R_SIAASE
.
R_UDPGDr
Chro.80111
R_GLCP
Chro.60284
R_GLPASE2
Chro.60284
R_GLPASE1
Chro.60284
R_TRE6PS
Chro.80565
R_GBEZ
Chro.60381
R_GLBRAN
Chro.60381
R_AMALT1
Chro.60114
R_AMALT2
Chro.60114
R_AMALT3
Chro.60114
R_AMALT4
Chro.60114
R_AMY2e
Chro.80574
R_AMY1e
Chro.80574
R_GLCGSD
Chro.80574
R_GLDBRAN
Chro.60114
R_PGI3
Chro.20336
R_PGI2
Chro.20336
R_PGI1
Chro.20336
R_DXPRIi
.
R_IPDDI
.
R_DMATT
Chro.40285
R_GRTT
Chro.40285
R_SQLS
Chro.10227
R_H2Ot
.
R_CYSt2r
.
R_METt2r
R_GLNt2r
R_ILEt2r
R_LEUt2r
R_SULabc
R_PROt2r
R_ARGt2r
R_ASPt2r
R_ALAt2
R_HISt2r
R_LYSt2r
R_SERt2r
R_THRt2
R_TRPt2r
R_TYRt2r
R_VALt2r
R_PIt2
R_CMPtrans
R_AMPtrans
R_GMPtrans
R_GLCt1r
R_CO2t
R_NH4t
R_PHEt2r
R_TRPTRS
Chro.70176
R_ALCD2m
Chro.80199
R_DOPABMO
.
R_G5SD2
Chro.70551
R_G5SD
Chro.70551
R_GLU5K
Chro.70551
R_OIVD2
.
R_OIVD3
.
R_LEUTRS
Chro.50330
R_ILETRS
Chro.30434
R_VALTRS
Chro.80361

or Chro.80016 or

or Chro.50082 or
or Chro.50082 or
or Chro.70613 or

or Chro.80198

or Chro.20246

or Chro.50331

1.1.1.105
retinoldehydrogenase(11-cis,NADPH)
1.1.1.105
retinoldehydrogenase(all-trans,NADPH)
1.1.1.105
retinoldehydrogenase(9-cis,NADPH)
1.1.1.105
retinoldehydrogenase(all-trans)
1.1.1.105
retinoldehydrogenase(11-cis,NADH)
1.1.1.105
retinoldehydrogenase(9-cis,NADH)
1.1.1.105
retinoldehydrogenase(13-cis,NADH)
2.5.1.9
riboflavinsynthase
2.5.1.9
riboflavinsynthase
Chro.70489
3.1.3.2
or Chro.70177
acidphosphatase(FMN)
1.8.2.2
sulfitereductase(NADPH2)
3.3.1.1
Se-Adenosylselenohomocysteinehydrolase
3.2.1.18
sialidase
1.1.1.22
UDPglucose6-dehydrogenase
2.4.1.1
glycogenphosphorylase
2.4.1.1
glycogenphosphorylase(amyls->glc-D)
2.4.1.1
glycogenphosphorylase(glygn2->dxtrn)
2.4.1.15
alpha,alpha-trehalose-phosphatesynthase(UDP-forming)
2.4.1.18
_1,4-alpha-glucanbranchingenzyme
2.4.1.18
_1,4-alpha-glucanbranchingenzyme(glygn1->glygn2)
2.4.1.25
Amylomaltase(maltotriose)
2.4.1.25
Amylomaltase(maltotetraose)
2.4.1.25
Amylomaltase(maltopentaose)
2.4.1.25
Amylomaltase(maltohexaose)
Chro.60381
3.2.1.1
or Chro.60429
alpha-amylase,extracellular(glygn2->glygn4)
Chro.60381
3.2.1.1
or Chro.60429
alpha-amylase,extracellular(strch1->strch2)
Chro.80206
3.2.1.3
glucan1,4-alpha-glucosidase
3.2.1.33
glycogendebranchingenzyme
5.3.1.9
glucose-6-phosphateisomerase
5.3.1.9
glucose-6-phosphateisomerase
5.3.1.9
glucose-6-phosphateisomerase
1.1.1.267
_1-deoxy-D-xylulosereductoisomerase
5.3.3.2
isopentenyl-diphosphateD-isomerase
2.5.1.1
dimethylallyltranstransferase
2.5.1.10
geranyltranstransferase
2.5.1.21
Squalenesynthase
.
H2Otransportviadiffusion

6.1.1.2
1.1.1.1
1.14.17.1
1.2.1.41
1.2.1.41
2.7.2.11
1.2.4.4
1.2.4.4
6.1.1.4
6.1.1.5
6.1.1.9

Retinol-Vit A Metabolism
[c] : nadp + retinol-cis_DASH_11 <==> h + nadph + retinal-11_DASH_cis
Retinol-Vit A Metabolism
[c] : nadp + retinol <==> h + nadph + retinal
Retinol-Vit A Metabolism
[c] : nadp + retinol-9_DASH_cis <==> h + nadph + retinal-cis_DASH_9
Retinol-Vit A Metabolism
[c] : nad + retinol <==> h + nadh + retinal
Retinol-Vit A Metabolism
[c] : nad + retinol-cis_DASH_11 <==> h + nadh + retinal-11_DASH_cis
Retinol-Vit A Metabolism
[c] : nad + retinol-9_DASH_cis <==> h + nadh + retinal-cis_DASH_9
Retinol-Vit A Metabolism
[c] : nad + retinol-cis_DASH_13 <==> h + nadh + retinal-cis_DASH_13
Riboflavin Metabolism-Vit B2
[c] : 2 dmlz --> 4r5au + ribflv
Riboflavin Metabolism-Vit B3
[c] : 4r5au + db4p --> dmlz + 2 h2o + pi
Riboflavin Metabolism-Vit B4
[c] : fmn + h2o --> pi + ribflv
Selenoamino acid metabolism
[c] : 3 h2o + h2s + 3 nadp <==> 5 h + 3 nadph + so3
Selenoamino acid metabolism
[c] : h2o + seahcys --> adn + selhcys
Sphingoglycolipid Metabolism
[c] : 2 h2o + s2l2n2m2mn --> 2 acnam + l2n2m2mn
Starch and Sucrose Metabolism
[c] : h2o + 2 nad + udpg <==> 3 h + 2 nadh + udpglcur
Starch and Sucrose Metabolism
[c] : glycogen + pi --> g1p
Starch and Sucrose Metabolism
[c] : glygn3 + 7 h2o --> Tyr-ggn + 7 glc-D
Starch and Sucrose Metabolism
[c] : glygn2 + 3 pi --> dxtrn + 3 g1p
Starch and Sucrose Metabolism
[c] : g6p + udpg --> h + tre6p + udp
Starch and Sucrose Metabolism
[c] : 14glun --> glycogen + h2o
Starch and Sucrose Metabolism
[c] : glygn1 --> glygn2
Starch and Sucrose Metabolism
[c] : malt + malttr --> glc-D + maltttr
Starch and Sucrose Metabolism
[c] : malt + maltttr --> glc-D + maltpt
Starch and Sucrose Metabolism
[c] : malt + maltpt --> glc-D + malthx
Starch and Sucrose Metabolism
[c] : malt + malthx --> glc-D + malthp
Starch and Sucrose Metabolism
[e] : glygn2 + 8 h2o --> 8 glc-D + glygn4
Starch and Sucrose Metabolism
[e] : 8 h2o + strch1 --> 8 glc-D + strch2
Starch and Sucrose Metabolism
[c] : glycogen + h2o --> glc-D
Starch and Sucrose Metabolism
[c] : dxtrn + h2o --> glc-D + glygn3
Starch and Sucrose Metabolism
[c] : g6p-A <==> f6p
Starch and Sucrose Metabolism
[c] : g6p-A <==> g6p-B
Starch and Sucrose Metabolism
[c] : g6p-B <==> f6p
Sterol Biosynthesis
[c] : dxyl5p + h + nadph --> 2me4p + nadp
Sterol Biosynthesis
[c] : ipdp <==> dmpp
Terpenoid Biosynthesis
[c] : dmpp + ipdp --> grdp + ppi
Terpenoid Biosynthesis
[c] : grdp + ipdp --> frdp + ppi
Terpenoid Biosynthesis
[c] : 2 frdp + h + nadph --> nadp + 2 ppi + sql
Transport, Extracellular
h2o[e] <==> h2o[c]
Transport, Extracellular
cys-L[e] + h[e] <==> cys-L[c] + h[c]
Transport, Extracellular
h[e] + met-L[e] <==> h[c] + met-L[c]
Transport, Extracellular
gln-L[e] + h[e] <==> gln-L[c] + h[c]
Transport, Extracellular
h[e] + ile-L[e] <==> h[c] + ile-L[c]
Transport, Extracellular
h[e] + leu-L[e] <==> h[c] + leu-L[c]
Transport, Extracellular
atp[c] + h2o[c] + so4[e] --> adp[c] + h[c] + pi[c] + so4[c]
Transport, Extracellular
h[e] + pro-L[e] <==> h[c] + pro-L[c]
Transport, Extracellular
arg-L[e] + h[e] <==> arg-L[c] + h[c]
Transport, Extracellular
asp-L[e] + h[e] <==> asp-L[c] + h[c]
Transport, Extracellular
ala-L[e] + h[e] --> ala-L[c] + h[c]
Transport, Extracellular
h[e] + his-L[e] <==> h[c] + his-L[c]
Transport, Extracellular
h[e] + lys-L[e] <==> h[c] + lys-L[c]
Transport, Extracellular
h[e] + ser-L[e] <==> h[c] + ser-L[c]
Transport, Extracellular
h[e] + thr-L[e] --> h[c] + thr-L[c]
Transport, Extracellular
h[e] + trp-L[e] <==> h[c] + trp-L[c]
Transport, Extracellular
h[e] + tyr-L[e] <==> h[c] + tyr-L[c]
Transport, Extracellular
h[e] + val-L[e] <==> h[c] + val-L[c]
Transport, Extracellular
h[e] + pi[e] <==> h[c] + pi[c]
Transport, Extracellular
cmp[e] + h[e] --> cmp[c] + h[c]
Transport, Extracellular
amp[e] + h[e] --> amp[c] + h[c]
Transport, Extracellular
gmp[e] + h[e] --> gmp[c] + h[c]
Transport, Extracellular
glc-D[e] <==> glc-D[c]
Transport, Extracellular
co2[e] <==> co2[c]
Transport, Extracellular
nh4[e] <==> nh4[c]
Transport, Extracellular
h[e] + phe-L[e] <==> h[c] + phe-L[c]
Tryptophanyl-tRNAsynthetase
Tryptophan metabolism
[c] : atp + trnatrp + trp-L --> amp + ppi + trptrna
alcoholdehydrogenase(ethanol),mitochondrial
Tyrosine metabolism
[c] : etoh + nad <==> acald + h + nadh
dopaminebeta-monooxygenase
Tyrosine metabolism
[c] : ascb-L + dopa + o2 --> dhdascb + h2o + nrpphr
glutamate-5-semialdehydedehydrogenase
Urea Cycle and Metabolism of Amino Groups
[c] : glu5p + h + nadh --> glu5sa + nad + pi
glutamate-5-semialdehydedehydrogenase
Urea Cycle and Metabolism of Amino Groups
[c] : glu5p + h + nadph --> glu5sa + nadp + pi
glutamate5-kinase
Urea Cycle and Metabolism of Amino Groups
[c] : atp + glu-L --> adp + glu5p
R_2_oxoisovalerate_dehydrogenase__acylating_3_methyl_2_oxobutanoate_
Valine, Leucine, and Isoleucine Biosynthesis
[c] : 1.0 3mob + 1.0 coa + 1.0 nad --> 1.0 co2 + 1.0 ibcoa + 1.0 nadh
R_2_oxoisovalerate_dehydrogenase__acylating_3_methyl_2_oxopentanoate_
Valine, Leucine, and Isoleucine Biosynthesis
[c] : 1.0 3mop + 1.0 coa + 1.0 nad --> 1.0 2mbcoa + 1.0 co2 + 1.0 nadh
Leucyl-tRNAsynthetase
Valine, Leucine, and Isoleucine Biosynthesis
[c] : atp + leu-L + trnaleu --> amp + leutrna + ppi
Isoleucyl-tRNAsynthetase
Valine, Leucine, and Isoleucine Biosynthesis
[c] : atp + ile-L + trnaile --> amp + iletrna + ppi
Valyl-tRNAsynthetase
Valine, Leucine, and Isoleucine Biosynthesis
[c] : atp + trnaval + val-L --> amp + ppi + valtrna

Appendix B: Gap Analysis Results

REACTION IDs

ENZYME NAME

PATHWAY

EC NUMBER

REACTION ADDED THROUGH GAP ANALYSIS

While integrating proteomic data, following highlighted reaction that were inserted through Gap Analysis algorithm were later found to be existing in oocyst stage of parasite
hence not included in the figure 8, gap analysis reaction classification

R_BIOMASS
R_UAG4E
R_DXPRIi
R_MECDPS
R_IPDDI
R_DXPS
R_CDPMEK
R_MEPCT
R_KAS2
R_KAS8
R_KAS13
R_KAS141
R_KAS7
R_KAS17
R_KAS100iso
R_KAS130iso
R_KAS1
R_KAS3
R_KAS6
R_KAS11
R_KAS180iso
R_KAS5
R_KAS9
R_KAS4
R_KAS12
R_KAS10
R_MAN1PT2r
R_PLA2_2
R_G3PCT
R_CDGPT_CT
R_PGPPH_CT
R_PAP_CT
R_GLUK
R_G3POA_CT
R_LYSLG_CT
R_UGT_CT
R_UGT1_CT
R_UGT2_CT
R_LIPO1S24_CT
R_LIPO2S24_CT
R_LIPO3S24_CT
R_LIPO4S24_CT
R_TECA1S45
R_TECA2S45
R_TECA3S45
R_TECA4S_CT
R_TEICH45
R_UAGPT3
R_PPTGS_CT
R_FRTT
R_GGTT
R_PPTT
R_HEXTT
R_ICHORS
R_2S6HCCi
R_SUCBZS
R_SUCBZL
R_NPHS
R_DHNAOT7
R_AMMQT7
R_H2CO3D2
R_MECDPDH
R_CLPNS2_CT
R_UPP3S
R_ADSL2r
R_ADSL1r
R_ADSL2
R_ADSL1
R_GMPS
R_CYTK2
R_UMPK5
R_CYTK9
R_CYTK8
R_CYTK5
R_CYTK7
R_CYTK6
R_CYTK1
R_UMPK3
R_UMPK2
R_UMPK7
R_UMPK6
R_UMPK4
R_CYTK11
R_CYTK10
R_CYTK13
R_CYTK12
R_CYTK14
R_UMPK
R_AP4AH1
R_CBPS
R_SIAASE
R_H2Ot
R_CYSt2r
R_DOPABMO
R_OIVD2
R_OIVD3

biomass
Biomass
.
[c] : 0.257980584 ala-L + 0.176597196 arg-L + 0.218152121 asn-L + 0.230278549 asp-L + 0.047389692 cys-L + 0.30817156
R_UDP_N_acetylglucosamine_4_epimerase
Aminosugar Metabolism
5.1.3.7
[c] : 1.0 uacgam --> 1.0 uacgala
_1-deoxy-D-xylulosereductoisomerase
Biosyhthesis of Steroids
1.1.1.267
[c] : dxyl5p + h + nadph --> 2me4p + nadp
_2-C-methyl-D-erythritol2,4-cyclodiphosphatesynthase
Biosyhthesis of Steroids
4.6.1.12
[c] : 2p4c2me --> 2mecdp + cmp
isopentenyl-diphosphateD-isomerase
Biosyhthesis of Steroids
5.3.3.2
[c] : ipdp <==> dmpp
_1-deoxy-D-xylulose5-phosphatesynthase
Biosynthesis of Steroids
2.2.1.7
[c] : g3p + h + pyr --> co2 + dxyl5p
_4-(cytidine5'-diphospho)-2-C-methyl-D-erythritolkinase
Biosynthesis of Steroids
2.7.1.148
[c] : 4c2me + atp --> 2p4c2me + adp + h
_2-C-methyl-D-erythritol4-phosphatecytidylyltransferase
Biosynthesis of Steroids
2.7.7.60
[c] : 2me4p + ctp + h --> 4c2me + ppi
R_b_ketoacyl_synthetase__n_C140_
Fatty Acid Biosynthesis
2.3.1.41
[c] : 1.0 accoa + 17.0 h + 6.0 malcoa + 12.0 nadph --> 6.0 co2 + 7.0 coa + 5.0 h2o + 12.0 nadp + 1.0 ttdca
R_b_ketoacyl_synthetase__palmitate__n_C160_
Fatty Acid Biosynthesis
2.3.1.41
[c] : 1.0 accoa + 20.0 h + 7.0 malcoa + 14.0 nadph --> 7.0 co2 + 8.0 coa + 6.0 h2o + 1.0 hdca + 14.0 nadp
R_b_ketoacyl_synthetase__n_C180_
Fatty Acid Biosynthesis
2.3.1.41
[c] : 1.0 accoa + 23.0 h + 8.0 malcoa + 16.0 nadph --> 8.0 co2 + 9.0 coa + 7.0 h2o + 16.0 nadp + 1.0 ocdca
R_b_ketoacyl_synthetase__n_C141_
Fatty Acid Biosynthesis
2.3.1.41
[c] : 1.0 accoa + 16.0 h + 6.0 malcoa + 11.0 nadph --> 6.0 co2 + 7.0 coa + 5.0 h2o + 11.0 nadp + 1.0 ttdce
R_b_ketoacyl_synthetase__n_C161_
Fatty Acid Biosynthesis
2.3.1.41
[c] : 1.0 accoa + 19.0 h + 7.0 malcoa + 13.0 nadph --> 7.0 co2 + 8.0 coa + 6.0 h2o + 1.0 hdcea + 13.0 nadp
R_b_ketoacyl_synthetase__n_C181_
Fatty Acid Biosynthesis
2.3.1.41
[c] : 1.0 accoa + 22.0 h + 8.0 malcoa + 15.0 nadph --> 8.0 co2 + 9.0 coa + 7.0 h2o + 15.0 nadp + 1.0 ocdcea
R_b_ketoacyl_synthetase__branched(iso)_C100
Fatty Acid Biosynthesis
2.3.1.41
[c] : 8.0 h + 1.0 ibcoa + 3.0 malcoa + 6.0 nadph --> 3.0 co2 + 4.0 coa + 1.0 dca + 2.0 h2o + 6.0 nadp
R_b_ketoacyl_synthetase__branched(iso)_C130
Fatty Acid Biosynthesis
2.3.1.41
[c] : 11.0 h + 1.0 ivcoa + 4.0 malcoa + 8.0 nadph --> 4.0 co2 + 5.0 coa + 1.0 trdca + 3.0 h2o + 8.0 nadp
R_b_ketoacyl_synthetase__Iso_C140_
Fatty Acid Biosynthesis
2.3.1.41
[c] : 14.0 h + 1.0 ibcoa + 5.0 malcoa + 10.0 nadph --> 5.0 co2 + 6.0 coa + 1.0 fa1 + 4.0 h2o + 10.0 nadp
R_b_ketoacyl_synthetase__Iso_C150_
Fatty Acid Biosynthesis
2.3.1.41
[c] : 14.0 h + 1.0 ivcoa + 5.0 malcoa + 10.0 nadph --> 5.0 co2 + 6.0 coa + 1.0 fa3 + 4.0 h2o + 10.0 nadp
R_b_ketoacyl_synthetase__Iso_C160_
Fatty Acid Biosynthesis
2.3.1.41
[c] : 17.0 h + 1.0 ibcoa + 6.0 malcoa + 12.0 nadph --> 6.0 co2 + 7.0 coa + 1.0 fa6 + 5.0 h2o + 12.0 nadp
R_b_ketoacyl_synthetase__Iso_C170_
Fatty Acid Biosynthesis
2.3.1.41
[c] : 17.0 h + 1.0 ivcoa + 6.0 malcoa + 12.0 nadph --> 6.0 co2 + 7.0 coa + 1.0 fa11 + 5.0 h2o + 12.0 nadp
R_b_ketoacyl_synthetase__Iso_C180_
Fatty Acid Biosynthesis
2.3.1.41
[c] : 20.0 h + 1.0 ibcoa + 7.0 malcoa + 14.0 nadph --> 7.0 co2 + 8.0 coa + 1.0 ocdcaiso + 6.0 h2o + 14.0 nadp
R_b_ketoacyl_synthetase__Iso_C161_
Fatty Acid Biosynthesis
2.3.1.41
[c] : 16.0 h + 1.0 ibcoa + 6.0 malcoa + 11.0 nadph --> 6.0 co2 + 7.0 coa + 1.0 fa5 + 5.0 h2o + 11.0 nadp
R_b_ketoacyl_synthetase__Iso_C171_
Fatty Acid Biosynthesis
2.3.1.41
[c] : 16.0 h + 1.0 ivcoa + 6.0 malcoa + 11.0 nadph --> 6.0 co2 + 7.0 coa + 1.0 fa9 + 5.0 h2o + 11.0 nadp
R_b_ketoacyl_synthetase__Anteiso_C150_
Fatty Acid Biosynthesis
2.3.1.41
[c] : 1.0 2mbcoa + 14.0 h + 5.0 malcoa + 10.0 nadph --> 5.0 co2 + 6.0 coa + 1.0 fa4 + 4.0 h2o + 10.0 nadp
R_b_ketoacyl_synthetase__Anteiso_C170_
Fatty Acid Biosynthesis
2.3.1.41
[c] : 1.0 2mbcoa + 17.0 h + 6.0 malcoa + 12.0 nadph --> 6.0 co2 + 7.0 coa + 1.0 fa12 + 5.0 h2o + 12.0 nadp
R_b_ketoacyl_synthetase__Anteiso_C171_
Fatty Acid Biosynthesis
2.3.1.41
[c] : 1.0 2mbcoa + 16.0 h + 6.0 malcoa + 11.0 nadph --> 6.0 co2 + 7.0 coa + 1.0 fa10 + 5.0 h2o + 11.0 nadp
mannose-1-phosphateguanylyltransferase(GDP)reversible
Fructose and Mannose Metabolism
2.7.7.22
[c] : gdp + h + man1p <==> gdpmann + pi
phospholipaseA2
Glycerophospholipid Metabolism
3.1.1.4
[c] : h2o + pchol_hs --> Rtotal2 + h + lpchol_hs
R_glycerol_3_phosphate_cytidylyltransferase
Glycerophospholipid Metabolism
2.7.7.39
[c] : 1.0 ctp + 1.0 glyc3p + 1.0 h --> 1.0 cdpglyc + 1.0 ppi
R_CDPdiacylglycerolsn_glycerol_3_phosphate_3_phosphatidyltransferase
Glycerophospholipid Metabolism
2.7.8.5
[c] : 1.0 cdpdag_CT + 1.0 glyc3p --> 1.0 cmp + 1.0 h + 1.0 pglyp_CT
R_Phosphatidylglycerophosphate_phosphohydrolase
Glycerophospholipid Metabolism
3.1.3.27
[c] : 1.0 h2o + 1.0 pglyp_CT --> 1.0 pgly_CT + 1.0 pi
R_phosphatidic_acid_phosphatase
Glycerophospholipid Metabolism
3.1.3.4
[c] : 1.0 12dag3p_CT + 1.0 h2o --> 1.0 12dgr_CT + 1.0 pi
Glucokinase
Glycolysis/Gluconeogenesis
2.7.1.2
[c] : atp + glc-D --> adp + g6p-B + h
R_glycerol_3_phosphate_O_acyltransferase
Miscellaneous
.
[c] : 1.0 glyc3p + 0.051 dcacoa + 0.022 trdacoa + 0.023 fa1coa + 0.0092 tdcoa + 0.022 ttdcecoa + 0.323 fa6coa + 0.2293 pm
R_lysylphosphatidylglycerol_synthesis
Miscellaneous
.
[c] : 1.0 atp + 1.0 lys-L + 1.0 pgly_CT --> 1.0 amp + 1.0 h + 1.0 lysylpgly_CT + 1.0 ppi
R_UDP_glucosyltransferase__diglucosyl_
Miscellaneous
.
[c] : 1.0 12dgr_CT + 2.0 udpg --> 1.0 d12dg_CT + 2.0 h + 2.0 udp
R_UDP_glucosyltransferase__monoglucosyl_
Miscellaneous
.
[c] : 1.0 12dgr_CT + 1.0 udpg --> 1.0 h + 1.0 m12dg_CT + 1.0 udp
R_UDP_glucosyltransferase__triglucosyl_
Miscellaneous
.
[c] : 1.0 12dgr_CT + 3.0 udpg --> 3.0 h + 1.0 t12dg_CT + 3.0 udp
R_lipoteichoic_acid_synthesis__n24___linked__glucose_substituted
Miscellaneous
.
[c] : 24.0 cdpglyc + 1.0 d12dg_CT + 24.0 udpg --> 24.0 cmp + 48.0 h + 1.0 lipo1_24_CT + 24.0 udp
R_lipoteichoic_acid_synthesis__n24___linked__N_acetylglucosamine_substituted
Miscellaneous
.
[c] : 24.0 cdpglyc + 1.0 d12dg_CT + 24.0 uacgam --> 24.0 cmp + 48.0 h + 1.0 lipo2_24_CT + 24.0 udp
R_lipoteichoic_acid_synthesis__n24___unliked__D_alanine_substituted
Miscellaneous
.
[c] : 24.0 ala-D + 24.0 atp + 24.0 cdpglyc + 1.0 d12dg_CT + 24.0 h2o --> 24.0 amp + 24.0 cmp + 48.0 h + 1.0 lipo3_24_CT
R_lipoteichoic_acid_synthesis__n24___linked__unsubstituted Miscellaneous
.
[c] : 24.0 cdpglyc + 1.0 d12dg_CT --> 24.0 cmp + 24.0 h + 1.0 lipo4_24_CT
R_glycerol_teichoic_acid__n45___unlinked__unsubstituted
Miscellaneous
.
[c] : 45.0 cdpglyc + 1.0 uacgam + 1.0 uacmam --> 45.0 cmp + 1.0 gtca1_45_CT + 46.0 h + 1.0 udp + 1.0 ump
R_glycerol_teichoic_acid__n45___unlinked__D_ala_substituted Miscellaneous
.
[c] : 45.0 ala-D + 45.0 atp + 45.0 cdpglyc + 45.0 h2o + 1.0 uacgam + 1.0 uacmam --> 45.0 amp + 45.0 cmp + 1.0 gtca2_45
R_glycerol_teichoic_acid__n45___unlinked__glucose_substituted
Miscellaneous
.
[c] : 45.0 cdpglyc + 1.0 h2o + 1.0 uacgam + 1.0 uacmam + 45.0 udpg --> 45.0 cmp + 1.0 gtca3_45_CT + 91.0 h + 46.0 udp
R_minor_teichoic_acid_synthesis__n30_
Miscellaneous
.
[c] : 30.0 h2o + 30.0 uacgala + 30.0 udpg --> 60.0 h + 1.0 tcam_CT + 30.0 udp + 30.0 ump
R_teichuronic_acid__n45___unlinked__GalNAc_GlcA_repeated Miscellaneous
.
[c] : 45.0 uacgala + 45.0 udpglcur <==> 45.0 h + 1.0 teich_45_CT + 45.0 udp + 45.0 ump
R_UDP_N_acetylglucosamine_N_acetylmuramyl__pentapeptide_pyrophosphoryl_undecaprenol_N_acetylglucosamine_transferase
Miscellaneous
.
[c] : 1.0 uacgam + 1.0 uagmda --> 1.0 h + 1.0 uaagmda + 1.0 udp
R_Peptidoglycan_subunit_synthesis
Miscellaneous
.
[c] : 1.0 uaagmda --> 1.0 h + 1.0 peptido_CT + 1.0 udcpdp
R_farnesyltranstransferase
Miscellaneous
.
[c] : 1.0 frdp + 1.0 ipdp --> 1.0 ggdp + 1.0 ppi
R_geranylgeranyltranstransferase
Miscellaneous
.
[c] : 1.0 ggdp + 1.0 ipdp --> 1.0 pendp + 1.0 ppi
R_trans_pentaprenyltranstransferase
Miscellaneous
.
[c] : 1.0 ipdp + 1.0 pendp --> 1.0 hexdp + 1.0 ppi
R_trans_hexaprenyltranstransferase
Miscellaneous
.
[c] : 1.0 hexdp + 1.0 ipdp --> 1.0 hepdp + 1.0 ppi
R_isochorismate_synthase
Miscellaneous
.
[c] : 1.0 chor <==> 1.0 ichor
R_2_succinyl_6_hydroxy_2_4_cyclohexadiene_1_carboxylate_synthase
Miscellaneous
.
[c] : 1.0 akg + 1.0 h + 1.0 ichor --> 1.0 2shchc + 1.0 co2 + 1.0 pyr
R_O_succinylbenzoate_CoA_synthase
Miscellaneous
.
[c] : 1.0 2shchc --> 1.0 h2o + 1.0 sucbz
R_o_succinylbenzoate_CoA_ligase
Miscellaneous
.
[c] : 1.0 atp + 1.0 coa + 1.0 sucbz --> 1.0 amp + 1.0 ppi + 1.0 sbzcoa
R_naphthoate_synthase
Miscellaneous
.
[c] : 1.0 sbzcoa --> 1.0 coa + 1.0 dhna
R_1_4_dihydroxy_2_naphthoate_octaprenyltransferase
Miscellaneous
.
[c] : 1.0 dhna + 1.0 hepdp + 1.0 nad --> 1.0 2dmmq7 + 1.0 co2 + 1.0 nadh + 1.0 ppi
R_S_adenosylmethione2_demthylmenaquinone_methyltransferase__menaquinone_7_
Miscellaneous
.
[c] : 1.0 2dmmq7 + 1.0 amet + 1.0 nadph --> 1.0 ahcys + 1.0 mql7 + 1.0 nadp
carboxylicaciddissociation
Miscellaneous
.
[c] : h + hco3 <==> h2co3
_2C-methyl-D-erythritol2,4cyclodiphosphatedehydratase
Miscellaneous
1.17.4.3
[c] : 2mecdp + h --> h2mb4p + h2o
R_cardiolipin_synthase
Miscellaneous
2.7.8.[c] : 2.0 pgly_CT --> 1.0 cdlp_CT + 1.0 glyc
uroporphyrinogen-IIIsynthase
Porphyrin and chlorophyll metabolism 4.2.1.75
[c] : hmbil --> h2o + uppg3
adenylosuccinatelyase
Purine Metabolism
4.3.2.2
[c] : 25aics <==> aicar + fum
adenylsuccinatelyase
Purine Metabolism
4.3.2.2
[c] : dcamp <==> amp + fum
adenylosuccinatelyase
Purine Metabolism
4.3.2.2
[c] : 25aics --> aicar + fum
adenylosuccinatelyase
Purine Metabolism
4.3.2.2
[c] : dcamp --> amp + fum
GMPsynthase
Purine Metabolism
6.3.4.1
[c] : atp + nh4 + xmp --> amp + gmp + 2 h + ppi
cytidylatekinase(dCMP)
Pyrimidine Metabolism
2.7.4.14
[c] : atp + dcmp <==> adp + dcdp
UMPkinase(dATP)
Pyrimidine Metabolism
2.7.4.14
[c] : datp + ump <==> dadp + udp
cytidylatekinase(CMP,dCTP)
Pyrimidine Metabolism
2.7.4.14
[c] : cmp + dctp <==> cdp + dcdp
cytidylatekinase(CMP,dATP)
Pyrimidine Metabolism
2.7.4.14
[c] : cmp + datp <==> cdp + dadp
cytidylatekinase(dCMP)
Pyrimidine Metabolism
2.7.4.14
[c] : ctp + dcmp <==> cdp + dcdp
cytidylatekinase(CMP,UTP)
Pyrimidine Metabolism
2.7.4.14
[c] : cmp + utp <==> cdp + udp
cytidylatekinase(CMP,CTP)
Pyrimidine Metabolism
2.7.4.14
[c] : cmp + ctp <==> 2 cdp
cytidylatekinase(CMP)
Pyrimidine Metabolism
2.7.4.14
[c] : atp + cmp <==> adp + cdp
UMPkinase(UTP)
Pyrimidine Metabolism
2.7.4.14
[c] : ump + utp <==> 2 udp
UMPkinase(CTP)
Pyrimidine Metabolism
2.7.4.14
[c] : ctp + ump <==> cdp + udp
UMPkinase(dGTP)
Pyrimidine Metabolism
2.7.4.14
[c] : dgtp + ump <==> dgdp + udp
UMPkinase(dCTP)
Pyrimidine Metabolism
2.7.4.14
[c] : dctp + ump <==> dcdp + udp
UMPkinase(GTP)
Pyrimidine Metabolism
2.7.4.14
[c] : gtp + ump <==> gdp + udp
cytidylatekinase(dCMP,dGTP)
Pyrimidine Metabolism
2.7.4.14
[c] : dcmp + dgtp <==> dcdp + dgdp
cytidylatekinase(CMP,dGTP)
Pyrimidine Metabolism
2.7.4.14
[c] : cmp + dgtp <==> cdp + dgdp
cytidylatekinase(dCMP,dATP)
Pyrimidine Metabolism
2.7.4.14
[c] : datp + dcmp <==> dadp + dcdp
cytidylatekinase(dCMP,dCTP)
Pyrimidine Metabolism
2.7.4.14
[c] : dcmp + dctp <==> 2 dcdp
cytidylatekinase(dCMP,UTP)
Pyrimidine Metabolism
2.7.4.14
[c] : dcmp + utp <==> dcdp + udp
UMPkinase
Pyrimidine Metabolism
2.7.4.14
[c] : atp + ump <==> adp + udp
Ap4Ahydrolase,asymmetrically
Pyrimidine Metabolism
3.6.1.17
[c] : ap4a + h2o --> amp + atp + 2 h
carbamoyl-phosphatesynthase(glutamine-hydrolysing)
Pyrimidine Metabolism
6.3.5.5
[c] : 2 atp + gln-L + h2o + hco3 --> 2 adp + cbp + glu-L + 2 h + pi
sialidase
Sphingoglycolipid Metabolism
3.2.1.18
[c] : 2 h2o + s2l2n2m2mn --> 2 acnam + l2n2m2mn
H2Otransportviadiffusion
Transport, Extracellular
.
h2o[e] <==> h2o[c]
Transport, Extracellular
cys-L[e] + h[e] <==> cys-L[c] + h[c]
dopaminebeta-monooxygenase
Tyrosine metabolism
1.14.17.1
[c] : ascb-L + dopa + o2 --> dhdascb + h2o + nrpphr
R_2_oxoisovalerate_dehydrogenase__acylating_3_methyl_2_oxobutanoate_
Valine, Leucine, and Isoleucine Biosynthesis
1.2.4.4
[c] : 1.0 3mob + 1.0 coa + 1.0 nad --> 1.0 co2 + 1.0 ibcoa + 1.0 nadh
R_2_oxoisovalerate_dehydrogenase__acylating_3_methyl_2_oxopentanoate_
Valine, Leucine, and Isoleucine Biosynthesis
1.2.4.4
[c] : 1.0 3mop + 1.0 coa + 1.0 nad --> 1.0 2mbcoa + 1.0 co2 + 1.0 nadh

Appendix C: Predicted Essential Reactions in the Model

REACTION IDs
R_biomass_target
R_G3POA_CT
R_LYSLG_CT
R_UGT_CT
R_UGT1_CT
R_UGT2_CT
R_AGPATr_CT
R_PHCYT_CT
R_CLPNS2_CT
R_CDPDSP_CT
R_PSDC_CT
R_P5CD
R_PRO1x
R_KAS12
R_KAS100iso
R_KAS130iso
R_KAS1
R_KAS6
R_KAS180iso
R_KAS7
R_KAS8
R_KAS2
R_FACOAL170_anteiso_
R_FACOAL100
R_FACOAL130
R_FACOAL140_ISO_
R_FACOAL160_ISO_
R_FACOAL180_ISO_
R_FACOAL161
R_GLNS
R_G3PD1ir
R_CDGPT_CT
R_PGPPH_CT
R_PAP_CT
R_GAPD
R_PYK
R_FBA
R_ENO
R_PGM
R_NADK
R_RNDR4
R_ADNK2
R_NDPK4
R_GK1
R_NTD7
R_NTD5
R_RNDR2
R_RNDR1
R_RNDR3
R_TRDR
R_DTMPK
R_DCMPDA

ENZYME NAME

PATHWAY

Biomass Rxn
Biomass Objective
R_glycerol_3_phosphate_O_acyltransferase
.
R_lysylphosphatidylglycerol_synthesis .
R_UDP_glucosyltransferase__diglucosyl_.
R_UDP_glucosyltransferase__monoglucosyl_
.
R_UDP_glucosyltransferase__triglucosyl_.
R_1_acylglycerol_3_phosphate_O_acyltransferase
.
R_phosphatidate_cytidylyltransferase
.
R_cardiolipin_synthase
.
R_CDPdiacylglycerol_serine_O_phosphatidyltransferase
.
R_phosphatidylserine_decarboxylase
.
_1-pyrroline-5-carboxylatedehydrogenase
Arginine and Proline Metabolism
prolineoxidase(L-proline,NAD)
Arginine and Proline Metabolism
R_b_ketoacyl_synthetase__Anteiso_C170_
Fatty Acid Biosynthsis
R_b_ketoacyl_synthetase__branched(iso)_C100
Fatty Acid Biosynthsis
R_b_ketoacyl_synthetase__branched(iso)_C130
Fatty Acid Biosynthsis
R_b_ketoacyl_synthetase__Iso_C140_ Fatty Acid Biosynthsis
R_b_ketoacyl_synthetase__Iso_C160_ Fatty Acid Biosynthsis
R_b_ketoacyl_synthetase__Iso_C180_ Fatty Acid Biosynthsis
R_b_ketoacyl_synthetase__n_C161_
Fatty Acid Biosynthsis
R_b_ketoacyl_synthetase__palmitate__n_C160_
Fatty Acid Biosynthsis
R_b_ketoacyl_synthetase__n_C140_
Fatty Acid Biosynthsis
R_fatty_acid__CoA_ligase__anteiso_C170_
Fatty Acid Biosynthsis
R_fatty_acid__CoA_ligase__Iso_C100_ Fatty Acid Biosynthsis
R_fatty_acid__CoA_ligase__Iso_C130_ Fatty Acid Biosynthsis
R_fatty_acid__CoA_ligase__Iso_C140_ Fatty Acid Biosynthsis
R_fatty_acid__CoA_ligase__Iso_C160_ Fatty Acid Biosynthsis
R_fatty_acid__CoA_ligase__Iso_C180_ Fatty Acid Biosynthsis
fatty-acid--CoAligase(hexadecenoate)
Fatty Acid Biosynthsis
glutaminesynthetase
Glutamate metabolism
glycerol-3-phosphatedehydrogenase(NAD)
Glycerolipid Metabolism
R_CDPdiacylglycerolsn_glycerol_3_phosphate_3_phosphatidyltransferase
Glycerophospholipid Metabolism
R_Phosphatidylglycerophosphate_phosphohydrolase
Glycerophospholipid Metabolism
R_phosphatidic_acid_phosphatase
Glycerophospholipid Metabolism
glyceraldehyde-3-phosphatedehydrogenase
Glycolysis/Gluconeogenesis
pyruvatekinase
Glycolysis/Gluconeogenesis
fructose-bisphosphatealdolase
Glycolysis/Gluconeogenesis
enolase
Glycolysis/Gluconeogenesis
phosphoglyceratemutase
Glycolysis/Gluconeogenesis
NADkinase
NAD Metabolism
ribonucleoside-diphosphatereductase(UDP)
Purine Metabolism
adenosinekinase
Purine Metabolism
nucleoside-diphosphatekinase(ATP:dTDP)Purine Metabolism
guanylatekinase(GMP:ATP)
Purine Metabolism
5'-nucleotidase(AMP)
Purine Metabolism
5'-nucleotidase(dTMP)
Purine Metabolism
ribonucleoside-diphosphatereductase(GDP)
Pyrimidine Metabolism
ribonucleoside-diphosphatereductase(ADP)
Pyrimidine Metabolism
ribonucleoside-diphosphatereductase(CDP)
Pyrimidine Metabolism
thioredoxinreductase(NADPH)
Pyrimidine Metabolism
dTMPkinase
Pyrimidine Metabolism
dCMPdeaminase
Pyrimidine Metabolism

EC NUMBER
.
.
.
.
.
.
2.3.1.51
2.7.7.41
2.7.8.2.7.8.8
4.1.1.65
1.5.1.12
1.5.1.2
2.3.1.41
2.3.1.41
2.3.1.41
2.3.1.41
2.3.1.41
2.3.1.41
2.3.1.41
2.3.1.41
2.3.1.41
6.2.1.3
6.2.1.3
6.2.1.3
6.2.1.3
6.2.1.3
6.2.1.3
6.2.1.3
6.3.1.2
1.1.1.8
2.7.8.5
3.1.3.27
3.1.3.4
1.2.1.12
2.7.1.40
4.1.2.13
4.2.1.11
5.4.2.1
2.7.1.23
1.17.4.1
2.7.1.20
2.7.4.6
2.7.4.8
3.1.3.5
3.1.3.5
1.17.4.1
1.17.4.1
1.17.4.1
1.8.1.9
2.7.4.9
3.5.4.12

GENE IDs

Chro.80165
Chro.70059
Chro.70250
Chro.30247
Chro.60426
Chro.60426

Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.50052
Chro.60524
Chro.20028

Chro.60434
Chro.10234
Chro.10335
Chro.50184
Chro.10196
Chro.80231
Chro.60090
Chro.20322
Chro.40275
Chro.70250
Chro.50026
Chro.50026
Chro.60090
Chro.60090
Chro.60090
Chro.20464
Chro.50490
Chro.20294

REACTION

[c] : 0.257980584 ala-L + 0.176597196 arg-L + 0.218152121 asn-L + 0.230278549 asp-L + 0.047389692 cys-L + 0.308
[c] : glyc3p + 0.051 dcacoa + 0.022 trdacoa + 0.023 fa1coa + 0.0092 tdcoa + 0.022 ttdcecoa + 0.323 fa6coa + 0.2293 p
[c] : atp + lys-L + pgly_CT --> amp + h + lysylpgly_CT + ppi
[c] : 12dgr_CT + 2.0 udpg --> d12dg_CT + 2.0 h + 2.0 udp
[c] : 12dgr_CT + udpg --> h + m12dg_CT + udp
[c] : 12dgr_CT + 3.0 udpg --> 3.0 h + t12dg_CT + 3.0 udp
[c] : 1ag3p_CT + 0.051 dcacoa + 0.022 trdacoa + 0.023 fa1coa + 0.0092 tdcoa + 0.022 ttdcecoa + 0.323 fa6coa + 0.229
or[c]
Chro.20170
: 12dag3p_CT + ctp + h --> cdpdag_CT + ppi
[c] : 2.0 pgly_CT --> cdlp_CT + glyc
[c] : cdpdag_CT + ser-L --> cmp + h + ps_CT
[c] : ps_CT --> co2 + psetha_CT
or[c]
Chro.70551
: 1pyr5c + 2 h2o + nad --> glu-L + h + nadh
[c] : nad + pro-L --> 1pyr5c + 2 h + nadh
[c] : 2mbcoa + 17.0 h + 6.0 malcoa + 12.0 nadph --> 6.0 co2 + 7.0 coa + fa12 + 5.0 h2o + 12.0 nadp
[c] : 8.0 h + ibcoa + 3.0 malcoa + 6.0 nadph --> 3.0 co2 + 4.0 coa + dca + 2.0 h2o + 6.0 nadp
[c] : 11.0 h + ivcoa + 4.0 malcoa + 8.0 nadph --> 4.0 co2 + 5.0 coa + trdca + 3.0 h2o + 8.0 nadp
[c] : 14.0 h + ibcoa + 5.0 malcoa + 10.0 nadph --> 5.0 co2 + 6.0 coa + fa1 + 4.0 h2o + 10.0 nadp
[c] : 17.0 h + ibcoa + 6.0 malcoa + 12.0 nadph --> 6.0 co2 + 7.0 coa + fa6 + 5.0 h2o + 12.0 nadp
[c] : 20.0 h + ibcoa + 7.0 malcoa + 14.0 nadph --> 7.0 co2 + 8.0 coa + ocdcaiso + 6.0 h2o + 14.0 nadp
[c] : accoa + 19.0 h + 7.0 malcoa + 13.0 nadph --> 7.0 co2 + 8.0 coa + 6.0 h2o + hdcea + 13.0 nadp
[c] : accoa + 20.0 h + 7.0 malcoa + 14.0 nadph --> 7.0 co2 + 8.0 coa + 6.0 h2o + hdca + 14.0 nadp
[c] : accoa + 17.0 h + 6.0 malcoa + 12.0 nadph --> 6.0 co2 + 7.0 coa + 5.0 h2o + 12.0 nadp + ttdca
or[c]
Chro.30084
: atp + coa + fa12 <==> amp + fa12coa + ppi
or[c]
Chro.30085
: atp + coa + dca <==> amp + dcacoa + ppi
or[c]
Chro.30086
: atp + coa + trdca <==> amp + trdacoa + ppi
or[c]
Chro.30087
: atp + coa + fa1 <==> amp + fa1coa + ppi
or[c]
Chro.30088
: atp + coa + fa6 <==> amp + fa6coa + ppi
or[c]
Chro.30089
: atp + coa + ocdcaiso <==> amp + ppi + strcoaiso
or[c]
Chro.30090
: atp + coa + hdcea <==> amp + hdcoa + ppi
[c] : atp + glu-L + nh4 --> adp + gln-L + h + pi
[c] : dhap + h + nadh --> glyc3p + nad
[c] : cdpdag_CT + glyc3p --> cmp + h + pglyp_CT
[c] : h2o + pglyp_CT --> pgly_CT + pi
[c] : 12dag3p_CT + h2o --> 12dgr_CT + pi
or[c]
Chro.10337
: g3p + nad + pi <==> 13dpg + h + nadh
[c] : adp + h + pep --> atp + pyr
[c] : fdp <==> dhap + g3p
[c] : 2pg <==> h2o + pep
or[c]
Chro.70471
: 2pg <==> 3pg
[c] : atp + nad --> adp + h + nadp
or[c]
Chro.60091
: trdrd + udp --> dudp + h2o + trdox
[c] : adn + gtp --> adp + gmp + h
or[c]
Chro.50237
: atp + dtdp
or Chro.40219
<==> adp + dttp
[c] : atp + gmp <==> adp + gdp
[c] : amp + h2o --> adn + pi
[c] : dtmp + h2o --> pi + thymd
or[c]
Chro.60091
: gdp + trdrd --> dgdp + h2o + trdox
or[c]
Chro.60091
: adp + trdrd --> dadp + h2o + trdox
or[c]
Chro.60091
: cdp + trdrd --> dcdp + h2o + trdox
[c] : h + nadph + trdox --> nadp + trdrd
[c] : atp + dtmp <==> adp + dtdp
[c] : dcmp + h + h2o <==> dump + nh4

Appendix D: Optimization result of oocyst and sporozoite stage data with nodel iNV213

Gene IDs

EC Numbers

Enzyme

Pathway

Reaction

Reaction present in oocyst stage only
Chro.40493 2.7.1.107
R_diacylglycerol_kinase
Chro.60435 2.7.1.1
hexokinase
Chro.40330 1.2.1.31
L-aminoadipate-semialdehydedehydrogenase(NADPH)
Chro.40330 1.2.1.31
L-aminoadipate-semialdehydedehydrogenase(NADH)
Chro.40159 3.6.1.1
inorganicdiphosphatase
Chro.50026 3.1.3.5
5'-nucleotidase(UMP)
Chro.50026 3.1.3.5
5'-nucleotidase(AMP)
Chro.20322 2.7.1.20
adenosinekinase
Chro.50398 or2.7.1.21
Chro.70052
thymidinekinase(ATP:thymidine)
Chro.10216 or2.7.1.48
Chro.20045 or Chro.80328
uridinekinase(ATP:Uridine)
Chro.10216 or2.7.1.48
Chro.20045 or Chro.80328
uridinekinase(GTP:Uridine)
Chro.50389 4.1.1.31
phosphoenolpyruvatecarboxylase
Chro.50314 1.1.1.38
malicenzyme(NAD)
Chro.50314 1.1.1.40
malicenzyme(NADP)

.
Glycolysis/Gluconeogenesis
Lysine Biosynthesis
Lysine Biosynthesis
Oxidative Phosphorylation
Purine Metabolism
Purine Metabolism
Purine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyruvate Metabolism
Pyruvate Metabolism
Pyruvate Metabolism

[c]
[c]
[c]
[c]
[c]
[c]
[c]
[c]
[c]
[c]
[c]
[c]
[c]
[c]

:
:
:
:
:
:
:
:
:
:
:
:
:
:

12dgr_CT + atp --> 12dag3p_CT + adp + h
atp + glc-D --> adp + h + g6p
L2aadp + atp + h + nadph --> L2aadp6sa + amp + nadp + ppi
L2aadp6sa + h2o + nad --> L2aadp + 2 h + nadh
h2o + ppi --> h + 2 pi
h2o + ump --> pi + uri
amp + h2o --> adn + pi
adn + gtp --> adp + gmp + h
atp + thymd --> adp + dtmp + h
atp + uri --> adp + h + ump
gtp + uri --> gdp + h + ump
co2 + h2o + pep --> h + oaa + pi
mal-L + nad --> co2 + nadh + pyr
mal-L + nadp --> co2 + nadph + pyr

Glycolysis/Gluconeogenesis
Nucleotide Salvage Pathway
Pentose Phosphate Pathway
Purine Metabolism
Purine Metabolism
Purine Metabolism
Pyrimidine Metabolism
Starch and Sucrose Metabolism
Starch and Sucrose Metabolism
Starch and Sucrose Metabolism

[c]
[c]
[c]
[c]
[c]
[c]
[c]
[c]
[c]
[c]

:
:
:
:
:
:
:
:
:
:

atp + glc-D --> adp + g6p-B + h
gdp + h2o --> gmp + h + pi
g6p <==> g6p-B
dcdp + h2o --> dcmp + h + pi
dudp + h2o --> dump + h + pi
h2o + udp --> h + pi + ump
ctp + dcmp <==> cdp + dcdp
g6p-A <==> g6p-B
g6p-A <==> f6p
g6p-B <==> f6p

Carbon Fixation
Fructose and Mannose Metabolism
Glycolysis/Gluconeogenesis
Glycolysis/Gluconeogenesis
Glycolysis/Gluconeogenesis
Glycolysis/Gluconeogenesis
Glycolysis/Gluconeogenesis
Glycolysis/Gluconeogenesis
Glycolysis/Gluconeogenesis
Glycolysis/Gluconeogenesis
Glycolysis/Gluconeogenesis
Glycolysis/Gluconeogenesis
IMP Biosynthesis
Nucleotides
Pentose Phosphate Pathway
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Purine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyrimidine Metabolism
Pyruvate Metabolism
Pyruvate Metabolism
Pyruvate Metabolism
Transport, Extracellular
Tyrosine metabolism

[c] : 3pg + atp <==> 13dpg + adp
[c] : dhap <==> g3p
[c] : 3pg + atp <==> 13dpg + adp
[c] : h + pyr --> acald + co2
[c] : 2pg <==> h2o + pep
[c] : 2pg <==> 3pg
[c] : g6p <==> f6p
[c] : g3p + nad + pi <==> 13dpg + h + nadh
[c] : adp + h + pep --> atp + pyr
[c] : etoh + nad <==> acald + h + nadh
[c] : fdp <==> dhap + g3p
[c] : atp + f6p --> adp + fdp + h
[c] : 25aics --> aicar + fum
[c] : dcamp --> amp + fum
[c] : atp + f6p --> adp + fdp + h
[c] : 25aics <==> aicar + fum
[c] : atp + dadp <==> adp + datp
[c] : atp + dcdp <==> adp + dctp
[c] : atp + dgdp <==> adp + dgtp
[c] : atp + cdp <==> adp + ctp
[c] : atp + udp <==> adp + utp
[c] : dcamp <==> amp + fum
[c] : atp + gdp <==> adp + gtp
[c] : atp + gmp <==> adp + gdp
[c] : ctp + ump <==> cdp + udp
[c] : dgtp + ump <==> dgdp + udp
[c] : atp + ump <==> adp + udp
[c] : dctp + ump <==> dcdp + udp
[c] : atp + dcmp <==> adp + dcdp
[c] : cmp + dctp <==> cdp + dcdp
[c] : cmp + datp <==> cdp + dadp
[c] : cmp + utp <==> cdp + udp
[c] : cmp + ctp <==> 2 cdp
[c] : atp + cmp <==> adp + cdp
[c] : ump + utp <==> 2 udp
[c] : datp + ump <==> dadp + udp
[c] : gtp + ump <==> gdp + udp
[c] : dcmp + dgtp <==> dcdp + dgdp
[c] : cmp + dgtp <==> cdp + dgdp
[c] : datp + dcmp <==> dadp + dcdp
[c] : dcmp + dctp <==> 2 dcdp
[c] : dcmp + utp <==> dcdp + udp
[c] : h + nadh + oaa --> mal-L + nad
[c] : lac-L + nad <==> h + nadh + pyr
[c] : mal-L + nad <==> h + nadh + oaa
h2o[e] <==> h2o[c]
[c] : etoh + nad <==> acald + h + nadh
glc-D[e] <==> glc-D[c]

Reactions presnt in sporozoite stage only

Chro.60194
Chro.20336
Chro.60194
Chro.60194
Chro.60194
Chro.20336
Chro.20336
Chro.20336

.
3.6.1.6
5.3.1.9
3.6.1.6
3.6.1.6
3.6.1.6
2.7.4.14
5.3.1.9
5.3.1.9
5.3.1.9

Glucokinase
nucleoside-diphosphatase(GDP)
Glucose-6-phosphateisomerase
nucleoside-diphosphatase(dCDP)
nucleoside-diphosphatase(dUDP)
nucleoside-diphosphatase(UDP)
cytidylatekinase(dCMP)
glucose-6-phosphateisomerase
glucose-6-phosphateisomerase
glucose-6-phosphateisomerase

Reactions commonly present in both the stages
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.

phosphoglyceratekinase
triose-phosphateisomerase
phosphoglyceratekinase
pyruvatedecarboxylase
enolase
phosphoglyceratemutase
glucose-6-phosphateisomerase
glyceraldehyde-3-phosphatedehydrogenase
pyruvatekinase
alcoholdehydrogenase(ethanol)
fructose-bisphosphatealdolase
phosphofructokinase,glycosome
adenylosuccinatelyase
adenylosuccinatelyase
phosphofructokinase
adenylosuccinatelyase
nucleoside-diphosphatekinase(ATP:dADP)
nucleoside-diphosphatekinase(ATP:dCDP)
nucleoside-diphosphatekinase(ATP:dGDP)
nucleoside-diphosphatekinase(ATP:CDP)
nucleoside-diphosphatekinase(ATP:UDP)
adenylsuccinatelyase
nucleoside-diphosphatekinase(ATP:GDP)
guanylatekinase(GMP:ATP)
UMPkinase(CTP)
UMPkinase(dGTP)
UMPkinase
UMPkinase(dCTP)
cytidylatekinase(dCMP)
cytidylatekinase(CMP,dCTP)
cytidylatekinase(CMP,dATP)
cytidylatekinase(CMP,UTP)
cytidylatekinase(CMP,CTP)
cytidylatekinase(CMP)
UMPkinase(UTP)
UMPkinase(dATP)
UMPkinase(GTP)
cytidylatekinase(dCMP,dGTP)
cytidylatekinase(CMP,dGTP)
cytidylatekinase(dCMP,dATP)
cytidylatekinase(dCMP,dCTP)
cytidylatekinase(dCMP,UTP)
malatedehydrogenase(otherdirection)
L-lactatedehydrogenase
malatedehydrogenase
H2Otransportviadiffusion
alcoholdehydrogenase(ethanol),mitochondrial
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